Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.781319024320011,-2.0378911480419344,0.0,0.011089569600620394,0.009,13/19,13.74%,GRM7;GRIA2;GRM5;GRIA1;GRM1;GRM3;GRIK4;GRIA4;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,platelet-derived growth factor binding (GO:0048407),-0.8043438487659289,-1.8417110570450765,0.0,0.14214811942613415,0.228,7/11,2.27%,COL1A2;COL3A1;COL1A1;PDGFRB;PDGFRA;COL5A1;COL6A1
prerank,adenylate cyclase binding (GO:0008179),-0.8236584631137516,-1.814408996929072,0.002105263157894737,0.1455085950626858,0.321,5/10,5.97%,ADCY5;ADCY2;AKAP12;AKAP6;CAP2
prerank,retinoid binding (GO:0005501),-0.678154748870219,-1.808454890035344,0.002403846153846154,0.11845676618844513,0.34,7/22,8.27%,ALDH1A2;PTGDS;RBP1;ABCA4;RBP4;CYP26B1;CRABP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7721938126569172,-1.8001227201266279,0.0,0.106863125242342,0.372,7/14,15.93%,SLC7A11;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,metalloendopeptidase activity (GO:0004222),-0.5258502611742105,-1.7984530731772448,0.0,0.09056481840506656,0.378,22/76,12.47%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;ADAMTSL1;MMP14;ADAMTS17;ADAMTSL4;MMP16;ADAM19;ADAMTS15;ADAMTS1;ADAM33;MMP2;ADAMTS14;ADAM9;MMP11
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.7451344405441818,-1.7938676404192075,0.0022675736961451248,0.08180357835262837,0.391,6/15,8.98%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7644082347784686,-1.7912209971836852,0.0,0.07435052345870492,0.402,6/13,8.98%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,death receptor activity (GO:0005035),0.83982131628756,1.753273433648887,0.005825242718446602,1.0,0.729,6/11,7.30%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B;TNFRSF25;TNFRSF1A
prerank,pre-mRNA binding (GO:0036002),-0.6212735384043424,-1.7501708034394485,0.0024937655860349127,0.11313601309723836,0.574,9/28,15.56%,CELF2;DDX5;CELF4;U2AF2;RBM4;CELF1;HNRNPU;HNRNPA1;RNPC3
prerank,leak channel activity (GO:0022840),-0.6657997624227423,-1.732131317594965,0.009501187648456057,0.12672353625436214,0.653,3/18,2.75%,KCNK2;NALCN;KCNK5
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.7290120666084893,-1.7269393854795143,0.004618937644341801,0.12262681095562057,0.679,7/15,15.93%,SLC1A3;SLC1A5;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7591216549841865,-1.7262408178577566,0.002304147465437788,0.11350006462453147,0.683,5/13,9.03%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,amino acid:sodium symporter activity (GO:0005283),-0.7549661797238941,-1.7244236476483439,0.01939655172413793,0.10647537805350911,0.689,6/11,7.50%,SLC6A13;SLC1A3;SLC6A1;SLC6A12;SLC6A15;SLC1A2
prerank,phospholipid transfer activity (GO:0120014),0.7334136432624271,1.711179066532451,0.005154639175257732,1.0,0.88,10/21,13.85%,CERT1;PLTP;PRELID2;PITPNM2;GLTP;ABCA3;PLEKHA8;PITPNC1;C2CD2L;PITPNB
prerank,sialyltransferase activity (GO:0008373),0.7399653050065563,1.7084510271563182,0.0016339869281045752,0.9759116447317787,0.886,6/20,7.31%,ST3GAL6;ST6GALNAC3;ST6GAL1;ST3GAL1;ST8SIA4;ST6GALNAC2
prerank,BMP receptor binding (GO:0070700),-0.7591273069482527,-1.7030074120609615,0.008869179600886918,0.12825015232925274,0.788,5/12,9.03%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.7247159166396119,-1.6984700990833297,0.015317286652078774,0.1260178363706863,0.806,5/12,8.72%,SULF1;SULF2;ARSI;ARSB;ARSG
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5883003668067944,-1.6858703456564264,0.011235955056179775,0.13351589763474214,0.848,13/29,13.74%,GRIA2;GABRG2;GABRA2;GRIK4;GRIA4;GABRB1;GRIK2;GRIK5;GABRB3;GRID2;GRIK1;GABRG3;GRIN2D
prerank,phosphatidylinositol binding (GO:0035091),0.5792980027945607,1.6762149356306302,0.00398406374501992,1.0,0.957,34/91,14.14%,EPB41;MCF2L;PARD3;HIP1;HIP1R;SCARB1;PITPNM2;DENND1B;MTM1;ESYT2;FCHO2;WDFY3;CCDC88A;EEA1;GRB7;ITPR3;PIGU;PLEKHF2;MYO1E;SNX24;MREG;PITPNC1;SH3YL1;PIGK;AIDA;ANKFY1;PICALM;PARD3B;SNX11;C2CD2L;ESYT1;EXOC8;PITPNB;SNX13
prerank,cadherin binding (GO:0045296),0.5122225246361879,1.6722996278744071,0.0,0.9059856845993997,0.965,86/315,14.47%,PTPRB;MRTFB;TJP1;DOCK9;FNBP1L;CLINT1;PKP4;BMPR2;KDR;ITGA6;EHD4;SPTBN1;EPN2;F11R;PPFIBP1;FLNB;PTPRM;CD2AP;LRRFIP1;TJP2;WASF2;IQGAP1;MYH9;DAB2IP;FASN;PTPRJ;SLC3A2;BSG;ESYT2;NCK1;COBLL1;STK24;PROM1;SWAP70;NUMB;TMOD3;PKN2;PAK2;TES;CDH2;PDLIM1;LASP1;CTNNA1;RPL34;TAGLN2;CHMP2B;ACVR1;UBAP2;SH3GLB1;FMNL2;UNC45A;HNRNPK;TBC1D2;TRIM25;CDH15;RPL15;PSEN1;SLK;RPL14;CHMP4B;PTPN1;CDH23;GAPVD1;SERBP1;TWF2;SPTAN1;FSCN1;SFN;CBL;STK38;PICALM;RAB11B;RPL6;RACK1;DBNL;HSP90AB1;LIMA1;CAPZA1;CAST;CDH5;TMPO;RARS1;APC;ERC1;RPL29;CNN3
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7691151646640935,1.6703003117086062,0.007326007326007326,0.660069597915361,0.965,4/16,5.16%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7691151646640935,1.6703003117086062,0.007326007326007326,0.660069597915361,0.965,4/16,5.16%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.5082932257903601,1.6584388087596853,0.0011061946902654867,0.6581681482336643,0.978,38/254,8.58%,MECOM;ERG;LEF1;ELK3;FOXO1;ESR1;MEF2C;ZBTB16;SMAD1;ZIC3;NFATC1;IRF2;HHEX;STAT3;NR3C1;HIF1A;KLF7;RREB1;SOX17;SOX18;TCF12;FOSL2;GTF2I;MAFF;FOXF1;ELK4;FOXF2;HOXA10;TCF4;ATMIN;KLF10;NR1I3;HOXD8;TCF3;NFKB1;NEUROD1;NRL;CREB1
prerank,poly(U) RNA binding (GO:0008266),-0.6297442942468057,-1.6519029955316027,0.007594936708860759,0.1780854412334922,0.933,5/20,6.19%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1
prerank,pyridoxal phosphate binding (GO:0030170),-0.6283932988903361,-1.647246885066173,0.011441647597254004,0.17536082030071948,0.939,9/20,22.95%,PYGB;ABAT;PYGM;ACCS;OAT;CBS;PDXK;CTH;PNPO
prerank,phosphatidylcholine transporter activity (GO:0008525),0.7367163372411195,1.6436046512291977,0.027923211169284468,0.6812363067292645,0.987,8/17,13.85%,ATP8B1;PLTP;ATP10A;PITPNM2;ABCA3;PITPNC1;ABCG1;PITPNB
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.676467303792554,-1.628129912381475,0.01569506726457399,0.20030203465235402,0.963,5/14,5.64%,TIMP3;COL4A3;TIMP2;RECK;NGF
prerank,anion transmembrane transporter activity (GO:0008509),0.8146494121962783,1.6245756499235997,0.014035087719298246,0.7498464557838836,0.992,3/12,0.92%,SLCO2B1;ABCG2;SLC39A8
prerank,glycerophospholipid flippase activity (GO:0140333),0.7986781268920685,1.6164665137799463,0.03165735567970205,0.7392164312252052,0.994,6/11,8.14%,ATP8B1;ATP8A1;ATP10A;ATP11C;ABCA3;ATP11A
prerank,estrogen receptor binding (GO:0030331),0.6467741858663659,1.6127792543467572,0.01848998459167951,0.7011669745247441,0.994,9/32,11.94%,LEF1;TACC1;ESR1;DDX54;NCOA1;NRIP1;CNOT1;MMS19;DCAF1
prerank,ligand-gated channel activity (GO:0022834),-0.558970077591834,-1.6029183335605253,0.020172910662824207,0.23948429623885228,0.985,14/29,13.74%,GRIN3A;GRIA2;GRIA3;GRIA1;ANXA6;GRIK4;GRIA4;GRIN2A;GABRB1;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8046411068405286,1.6016455131876663,0.02394106813996317,0.7170447400671367,0.998,1/10,0.03%,MECOM
prerank,voltage-gated calcium channel activity (GO:0005245),-0.523239704201286,-1.5998618466502232,0.006042296072507553,0.23528130135342232,0.988,7/37,5.58%,CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;CACNB2;CACNA1G;ITGAV
prerank,ligand-gated ion channel activity (GO:0015276),-0.5551641399238675,-1.5985598768791842,0.020895522388059702,0.22719870280940463,0.988,14/30,13.74%,GRIN3A;GRIA2;GRIA3;GRIA1;ANXA6;GRIK4;GRIA4;GRIN2A;GABRB1;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,calcium channel activity (GO:0005262),-0.44164507537931946,-1.5742276206215782,0.0041841004184100415,0.26715781310585496,0.998,19/84,10.29%,SLC24A3;CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;PKD1;P2RX4;MCU;CACNB2;ITGAV;TRPC3;ANXA2;TRPC6;ANXA6;TRPC1;CACNB1;RYR2;SLC24A2;TRPC4
prerank,solute:anion antiporter activity (GO:0140323),-0.6476596706721119,-1.5626840006334106,0.02320185614849188,0.2833301021067597,0.999,6/14,14.47%,SLC7A11;SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC26A6
prerank,poly-pyrimidine tract binding (GO:0008187),-0.577634204498491,-1.561343385292076,0.017412935323383085,0.27518262892594025,0.999,6/23,10.00%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1;U2AF2
prerank,alkali metal ion binding (GO:0031420),-0.654258181212645,-1.55145699414753,0.033112582781456956,0.28751454051958125,0.999,2/13,2.18%,ATP1A2;HDAC4
prerank,actin monomer binding (GO:0003785),0.6628171709372114,1.5507039893883143,0.03934426229508197,1.0,1.0,8/22,13.48%,NOS3;MTSS1;TMSB4X;MRTFA;TWF2;ABL2;PFN4;LIMA1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.4743112298778406,-1.543381260279201,0.028846153846153848,0.29460169747102666,1.0,10/55,4.86%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC22A4;SLC38A11;SLC16A11
prerank,phospholipase inhibitor activity (GO:0004859),-0.692188350958352,-1.5399541393521035,0.044543429844097995,0.2915692682656622,1.0,6/10,18.10%,ANXA5;ANXA1;ANXA2;ANXA4;SNCA;ANGPTL3
prerank,metallopeptidase activity (GO:0008237),-0.4245143936676057,-1.53932100060467,0.0045662100456621,0.283566204489845,1.0,21/113,9.27%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS10;ADAMTS5;ADAMTSL1;MMP14;ADAMTS17;ADAMTSL4;MMP16;ADAM19;ADAMTS15;ADAMTS1;ADAM33;MMP2;ADAM12
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6192283389305704,1.5369811492240188,0.03225806451612903,1.0,1.0,10/35,7.46%,PEAK1;LYN;PTK2B;YES1;FYN;SRMS;DYRK1A;BMX;LCK;PTK2
prerank,ligand-gated anion channel activity (GO:0099095),-0.6074871389867438,-1.5341922576252391,0.04838709677419355,0.28574124337598555,1.0,10/17,22.92%,GLRB;GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;CFTR;GABRA1;GABRA5;GABRA3
prerank,growth factor receptor binding (GO:0070851),0.5257145322870026,1.5329292636007374,0.011734028683181226,1.0,1.0,20/95,8.58%,IL1R1;IL6ST;ERN1;PDGFB;VEGFC;HIP1;IL6R;PDGFD;PTPRJ;FYN;FGF23;SDCBP;VEGFD;IL27RA;CCDC88A;PDGFC;TGFA;ERAP1;ITGA5;PSEN1
prerank,SH3 domain binding (GO:0017124),0.5563712486620682,1.5326941578769324,0.024079320113314446,0.9771799747375284,1.0,13/62,6.17%,SHANK3;ABI3;CD2AP;ELMO1;WASF2;PTPN12;DAB2IP;AFAP1L1;AFAP1L2;ARHGAP27;EVL;SKAP1;ADAM15
prerank,cytokine receptor activity (GO:0004896),0.5261800215556207,1.5300248245382155,0.021164021164021163,0.9409707791374843,1.0,12/83,6.16%,IL1R1;IL6ST;LIFR;IL6R;FZD4;OSMR;GHR;CSF2RB;IL27RA;CX3CR1;IFNAR1;IFNAR2
prerank,protein phosphatase 2A binding (GO:0051721),0.6570112672679825,1.528517803809546,0.0448,0.9019212774489908,1.0,4/23,2.51%,FOXO1;CTTNBP2NL;DAB2IP;MFHAS1
prerank,protein kinase C activity (GO:0004697),0.6999624042172273,1.525666864184851,0.05605786618444846,0.8751359963057032,1.0,4/14,4.31%,PRKCH;PRKD1;PRKD3;PKN1
prerank,cation channel activity (GO:0005261),-0.42266757691949275,-1.5188751432163914,0.009389671361502348,0.31002013783787163,1.0,22/94,10.14%,SLC24A3;TRPM3;NALCN;PIEZO2;CACNA1D;KCNK5;PKD1;MCU;ANO1;ABCC9;CACNB2;TRPC3;ANXA2;TRPC6;ANXA6;KCNQ4;TRPC1;CALHM5;RYR2;SLC24A2;UNC80;TMEM38A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6839060514764442,-1.5141697528806284,0.0423728813559322,0.31047644435827837,1.0,4/10,8.65%,CACNA1C;CACNA1D;CACNB2;CACNB1
prerank,gap junction channel activity (GO:0005243),-0.5581084762445575,-1.5128194912867394,0.03836930455635491,0.3041535948864371,1.0,3/22,3.58%,GJB6;GJA1;GJB2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7181402343525302,1.5030986608082233,0.0641025641025641,0.9850575584655474,1.0,8/13,7.98%,IL1R1;ERN1;PDGFB;PDGFD;PTPRJ;VEGFD;PDGFC;ITGA5
prerank,wide pore channel activity (GO:0022829),-0.5510956590025987,-1.50283262425604,0.03667481662591687,0.31682366626371367,1.0,3/23,3.58%,GJB6;GJA1;GJB2
prerank,potassium ion leak channel activity (GO:0022841),-0.6042765125808172,-1.5025267425857904,0.05755395683453238,0.30831883897413176,1.0,2/15,2.75%,KCNK2;KCNK5
prerank,fatty acid synthase activity (GO:0004312),0.7423630495686351,1.4975724967383786,0.09177820267686425,0.9800882643101531,1.0,2/10,3.86%,ELOVL7;ELOVL5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.679403602266766,-1.4951187015475873,0.04811715481171548,0.31619275343587094,1.0,3/10,2.76%,SLC6A13;SLC6A1;SLC6A12
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5562739787967759,-1.4944945814699897,0.043596730245231606,0.30941806482713813,1.0,4/22,3.91%,RBMS3;CPEB1;CPEB2;CPEB3
prerank,ion channel activity (GO:0005216),-0.42795652381813676,-1.491881748104224,0.0,0.3068202689741026,1.0,23/80,13.74%,TRPM3;NALCN;PIEZO2;GRIN3A;GRIA2;ABCC9;GRIA3;GRIA1;TRPC6;ANXA6;TRPC1;CALHM5;GRIK4;GRIA4;UNC80;GRIN2A;GABRB1;GRIK2;GRIK5;TMEM63A;GRID2;GRIK1;GRIN2D
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.647278076172192,-1.4909431240424686,0.05672268907563025,0.3009952177846711,1.0,8/12,22.92%,GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.568038387055655,-1.487102124419368,0.03970223325062035,0.3021403644823575,1.0,11/19,22.92%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1;GABRG3;GABRA1;GABRA5;GABRA3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5872377449647689,-1.4862127298072267,0.059496567505720827,0.2969103169123975,1.0,5/18,10.97%,ALDH1A1;ALDH1A2;AKR1B1;ALDH2;FAR1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.5226793341261673,-1.4861978409891041,0.040345821325648415,0.2898890304473864,1.0,10/29,15.93%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A12;SLC25A13;SLC19A1;SLC26A6;SLC1A1;SLC25A18
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.6763176917964859,1.4852858946589464,0.07241379310344828,1.0,1.0,2/15,6.32%,PLA2G4A;PLA2G2D
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.6338604619053338,1.4833078583264672,0.044585987261146494,0.9896779034864928,1.0,6/25,4.08%,NOS3;FMO2;FMO4;FMO1;CH25H;CYP26A1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7536622192964307,1.4772973828695892,0.09230769230769231,0.9898570307088433,1.0,4/10,8.27%,CASP4;CASP8;CASP7;CASP1
prerank,GTPase activator activity (GO:0005096),0.4478217535031128,1.4733090834022922,0.0065717415115005475,0.9781188391382343,1.0,68/313,10.32%,CHN2;FGD5;TBC1D8;ARHGAP31;RGS3;DOCK9;GNAQ;PREX2;RAPGEF5;DENND5B;RALGAPA2;TBC1D30;ARAP3;ARHGEF15;RASGRF2;RIN3;CYTH1;DOCK1;ELMO1;TBC1D4;IQGAP1;FGD6;ARHGEF2;BCR;SRGAP2;DENND4C;DENND1B;SPATA13;DOCK4;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;ADRB1;TBC1D15;KALRN;ARHGAP8;PREX1;SIPA1L3;DENND2D;ARHGAP17;HERC2;RAP1GDS1;MYCBP2;CCDC88A;OPHN1;RAPGEF2;PGAM5;TBC1D12;SMAP1;ARRB1;RASA1;RAP1A;TBC1D2;BNIP2;RASA4;EIF2B5;ARHGEF7;LLGL1;CYTH2;ARHGAP28;NPRL2;GAPVD1;OCRL;RGL2;LARS1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7238192450511685,1.4699793720219558,0.08304498269896193,0.9633432532047171,1.0,9/12,22.17%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;CNOT7;PAN2;TOE1;NOCT
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5995997705982206,1.4684605493180847,0.05591054313099041,0.9388896493716397,1.0,10/29,15.48%,GCH1;NFATC1;PTPRJ;PPM1D;DUSP16;MAPKAPK3;TNIP1;DUSP7;DUSP2;ACE
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7241157273070096,1.4661733510256567,0.09293680297397769,0.9194511102795404,1.0,2/11,2.03%,LEF1;GATA2
prerank,hexose transmembrane transporter activity (GO:0015149),0.6943855119117907,1.4604950505131407,0.0677361853832442,0.9230027707226969,1.0,3/12,6.84%,SLC2A1;MFSD4A;PPBP
prerank,FMN binding (GO:0010181),0.7195279419408295,1.458897985224994,0.08093525179856115,0.9022811538719361,1.0,1/11,0.31%,NOS3
prerank,Hsp90 protein binding (GO:0051879),0.591196652232561,1.4559007388438185,0.05828220858895705,0.8902249769106442,1.0,7/33,6.73%,KDR;ERN1;AHR;NR3C1;HIF1A;UNC45B;UNC45A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.7013780674865229,1.4557565606794292,0.08828828828828829,0.8640325210078154,1.0,9/12,14.62%,VEGFC;DAB2IP;VEGFD;GREM1;CCDC88A;ITGA5;ITGB3;CDH5;PGF
prerank,actin binding (GO:0003779),0.46621621826446297,1.4554049271944844,0.011723329425556858,0.8405222948103277,1.0,20/170,4.27%,MYRIP;FLII;NOS3;PARVB;ABLIM1;SLC6A2;UTRN;LCP1;EPS8;FLNB;MYH9;KLHL2;MTSS1;ACTN4;SHROOM2;SSH2;TMSB4X;SORBS1;PDLIM1;MRTFA
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.583748713064381,-1.4488320078385886,0.06852791878172589,0.36522899627582356,1.0,11/17,13.74%,GRIN3A;GRIA2;GRIA3;GRIA1;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;GRIN2D
prerank,1-phosphatidylinositol binding (GO:0005545),0.6806741351628083,1.445055536399744,0.08468468468468468,0.8718946465679323,1.0,5/15,11.71%,EPB41;SCARB1;WDFY3;EEA1;PICALM
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4681465666422096,1.441711152729316,0.030562347188264057,0.8656710023345904,1.0,26/147,6.11%,FGD5;DOCK9;PREX2;RAPGEF5;DENND5B;ARHGEF15;RASGRF2;RIN3;CYTH1;DOCK1;ELMO1;FGD6;ARHGEF2;BCR;DENND4C;DENND1B;SPATA13;DOCK4;ADRB1;KALRN;PREX1;DENND2D;HERC2;MYCBP2;CCDC88A;RAPGEF2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.599602017956888,1.4371701026879877,0.07190635451505016,0.8654857189214151,1.0,6/24,9.21%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;SNX3;PLEKHA8
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5002151345977641,-1.436393221120058,0.04285714285714286,0.38641651098029534,1.0,12/28,22.92%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1;GABRG3;CHRNA7;GABRA1;GABRA5;GABRA3
prerank,alanine transmembrane transporter activity (GO:0022858),0.6837910660439609,1.4358440276078235,0.09694793536804308,0.8488378155038948,1.0,3/12,4.79%,SLC38A5;SLC3A2;SLC6A6
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.4582350306148419,-1.4356129159521245,0.0425531914893617,0.3797337469303348,1.0,9/47,3.68%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC1A5;SLC22A4;SLC38A11
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5855760408759858,-1.43313240613283,0.08372093023255814,0.3776151862029435,1.0,6/16,15.93%,SLC13A3;SLC1A5;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,BMP binding (GO:0036122),0.675486859620275,1.4319349073657852,0.10126582278481013,0.8482260862357839,1.0,4/11,6.58%,BMPR2;ENG;GREM1;SOST
prerank,endopeptidase inhibitor activity (GO:0004866),-0.40806744515773896,-1.4255491465888421,0.030418250950570342,0.38789898773233894,1.0,18/82,12.41%,TIMP3;SERPING1;COL4A3;TIMP2;TFPI;SERPINH1;ITIH2;RENBP;RECK;SERPINE2;NGF;SERPIND1;ANXA2;SERPINF1;BIN1;SERPINE1;CST3;SPOCK3
prerank,GABA receptor activity (GO:0016917),-0.5411253109797729,-1.4247774660578312,0.07142857142857142,0.38149799663952433,1.0,11/21,23.00%,GPR156;GABRG2;GABRA2;GABBR1;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3;GABBR2
prerank,TBP-class protein binding (GO:0017025),0.6191441045955858,1.4228261242921982,0.1077943615257048,0.8738174209189563,1.0,6/21,12.88%,ESR1;AHR;HHEX;TAF1B;YEATS2;GTF2A2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7066747184978446,1.4212478471035253,0.11842105263157894,0.8612669861632812,1.0,4/11,8.27%,CASP4;CASP8;CASP7;CASP1
prerank,antiporter activity (GO:0015297),0.6316986267960364,1.4196520833701323,0.11130742049469965,0.8491246385416323,1.0,6/20,10.18%,SLC25A16;SLC35E4;CLCN3;ATP1A3;SLC25A30;SLC35D2
prerank,calcium channel regulator activity (GO:0005246),0.552834782672648,1.418733902757652,0.0889894419306184,0.8340524504250053,1.0,4/37,8.74%,PRKG1;FKBP1A;SGK3;MCUB
prerank,CARD domain binding (GO:0050700),0.6676124893684543,1.4165974798373853,0.10479573712255773,0.8244827984299239,1.0,10/14,20.06%,NOD1;CASP4;CARD10;CASP1;CARD16;RIPK2;IRGM;CARD9;BCL10;CARD19
prerank,protein kinase C binding (GO:0005080),0.5467986880409926,1.411083654960816,0.07208588957055215,0.8336271325585571,1.0,12/43,10.18%,NELL2;HDAC9;ADCY4;CAVIN2;PRKD2;HDAC7;TIRAP;PKN1;CCDC88A;TRPV4;HINT1;TWF2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.580422503200939,-1.4097091985214723,0.10416666666666667,0.41132221791392015,1.0,11/14,38.89%,ALDH4A1;ALDH1L1;MTHFD1;NOXRED1;AASS;BLVRB;PYCR1;PYCR2;MTHFR;CRYM;ALDH1L2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.684869560620245,1.4091171858158764,0.11754068716094032,0.8250669089375885,1.0,1/12,0.26%,ENTPD1
prerank,glutamate receptor binding (GO:0035254),0.6412279232331626,1.4077908346831765,0.10918544194107452,0.8131867732379628,1.0,3/17,3.95%,SHANK3;HIP1;HOMER2
prerank,GTPase regulator activity (GO:0030695),0.4372564252202338,1.398682757129561,0.024110218140068886,0.837792946201801,1.0,44/212,10.32%,CHN2;TBC1D8;ARHGAP31;RGS3;GNAQ;PREX2;RALGAPA2;TBC1D30;ARAP3;DOCK1;TBC1D4;SH3BP4;IQGAP1;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;TBC1D15;ARHGAP8;PREX1;SIPA1L3;ARHGAP17;RAP1GDS1;CCDC88A;OPHN1;RAPGEF2;PGAM5;TBC1D12;SMAP1;ARRB1;RASA1;TBC1D2;BNIP2;RASA4;LLGL1;ARHGAP28;NPRL2;OCRL;RGS12;LARS1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.43540139023525143,-1.3985023645560422,0.0625,0.4314447460255913,1.0,11/48,9.97%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;ABCC9;TRPC6;TRPC1;CALHM5;ATP6V1B2;UNC80
prerank,retinoic acid receptor binding (GO:0042974),0.6307951680994355,1.3984186535491594,0.125,0.8217309006262399,1.0,6/17,14.92%,TACC1;ACTN4;NRIP1;CNOT1;ASXL1;SNW1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.628954098220562,1.3979672542026855,0.0893169877408056,0.8071870699607481,1.0,8/18,16.67%,RPS6KA3;RPS6KA1;SERPINB9;XIAP;GAS6;TNFAIP8;BIRC3;BIRC2
prerank,protein phosphatase binding (GO:0019903),0.4649701594434965,1.3932568775112018,0.05783132530120482,0.8124726889139401,1.0,27/117,10.15%,FOXO1;PPP1R16B;CTTNBP2NL;IQGAP1;DAB2IP;KCNQ1;STAT3;MFHAS1;PXN;FLT4;PPP1R9B;JAK3;CEACAM1;ATP2B4;PPP3CB;SKAP1;CDKN1B;LCK;JAK1;PTK2;SNX3;SHOC2;ANAPC7;FBXL2;ANK1;SMG7;AP3B1
prerank,FAD binding (GO:0071949),-0.5181487233773894,-1.392266927669524,0.10353535353535354,0.4393723057272541,1.0,6/24,10.63%,MICAL3;MICAL2;DDO;PRODH;CRY2;AIFM1
prerank,peptidase inhibitor activity (GO:0030414),-0.4801781720592334,-1.3920979848475799,0.07692307692307693,0.4314656843737883,1.0,7/33,6.42%,GPC3;TIMP2;TFPI;ITIH2;RENBP;RECK;SERPIND1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.6447169399217783,1.3883831610942459,0.13227513227513227,0.8184927534944852,1.0,7/14,19.58%,NOD1;MAL;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,AMP binding (GO:0016208),-0.6038140273029219,-1.388218259485294,0.10642570281124498,0.4332921199528851,1.0,7/11,18.15%,MPPED2;PFKP;PRKAG2;PRKAG3;ACSS2;PRKAG1;PFKM
prerank,protein kinase binding (GO:0019901),0.4116067199402931,1.3846018824873814,0.0041841004184100415,0.8203801466391918,1.0,112/480,14.29%,NELL2;FRMD5;HDAC9;BMPR2;CAV1;ESR1;UTRN;SLC12A7;ADCY4;ACVRL1;GCH1;CAVIN2;SMAD1;PLCG1;NEDD9;TJP2;IQGAP1;DAB2IP;PRKD2;KCNQ1;ADAM10;STAT3;NR3C1;HDAC7;TRIM14;HIF1A;MSN;PTPRJ;SIK1;CCNK;TAOK2;PRKAR2B;PLCG2;CAV2;PPP1R12A;PAK2;TIRAP;PKN1;RPS19;IKBKB;CEACAM1;GHR;PTPRK;TRIM68;TCF7L2;LRBA;CCDC88A;AURKA;DUSP22;RPS7;SKAP1;IFNAR2;ACVR1;RAC1;SASH1;CDKN1B;TRIB3;GNAT1;HNRNPA0;PPM1D;LCK;PTK2;AP2A1;GRB7;TCF3;TRPV4;RHOBTB1;DUSP16;POLA1;RPTOR;NEK6;ARHGEF7;LLGL1;MAP3K11;CRK;HINT1;RELB;PTPN1;RICTOR;MAP2K3;BCL2L1;MAPKAPK3;SPAG9;MAD2L2;TWF2;TNIP1;PRKAB1;EPHA4;PICK1;MAP3K13;STK38;IRAK4;PEBP1;RHOB;RELA;ADIPOR1;GSTP1;CEP68;ZFP36;RACK1;MYH6;WARS1;DUSP7;TRIB1;CDC25C;GSKIP;RPS6;CDH5;NPM1;TRAF6;BCL2L14;APC
prerank,semaphorin receptor activity (GO:0017154),0.6775841778580365,1.3735723194097829,0.14862385321100918,0.8553324867236205,1.0,3/11,2.82%,NRP2;PLXNA4;PLXND1
prerank,NAD binding (GO:0051287),-0.49796075337230444,-1.3723205966103573,0.07407407407407407,0.4638016457714014,1.0,6/26,7.59%,ALDH1A1;ME1;CRYL1;SIRT2;ALDH2;BDH2
prerank,cytokine receptor binding (GO:0005126),0.47339108027676907,1.368281232809163,0.071334214002642,0.8643702693058499,1.0,17/83,9.60%,IL6ST;LIFR;KITLG;VEGFC;IL6R;SOCS2;OSMR;PXDN;FKBP1A;SDCBP;VEGFD;IL27RA;USP15;JAK1;ERAP1;CSF1;IL23A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6648593232067158,1.3672164321342029,0.1590909090909091,0.8532000197908765,1.0,4/12,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,N-acyltransferase activity (GO:0016410),0.5510959104442418,1.3629393206481155,0.11912225705329153,0.8569823427189539,1.0,6/32,10.43%,TGM2;NMT2;CERS4;GLYAT;PLAAT3;SMARCE1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3846421475399967,-1.3624553480831891,0.04059040590405904,0.48238711269343293,1.0,19/79,16.22%,CELF2;RBMS3;CPEB1;DDX5;CPEB2;CPEB3;HNRNPA2B1;FXR2;DAZAP1;RBMS1;CPEB4;CIRBP;RBM4;CELF1;IGF2BP2;CSDC2;HNRNPU;ELAVL4;PCBP4
prerank,GTPase activity (GO:0003924),0.43518236673313443,1.3623050457145562,0.027677496991576414,0.8453466588109778,1.0,52/192,17.97%,DNM3;RAB27A;GNAQ;GCH1;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;GPN3;RHOJ;RALB;GBP7;GNAI2;NRAS;KRAS;RAC1;GNAT1;RAP1A;RHOBTB1;RAB2A;GNA12;RAB38;ARL8B;DRG2;RNF112;RAB11B;RAB43;RHOB;HBS1L;GNA13;RAB31;RAB5A;RAB7A;ATL1;GBP3;RAB5B;NKIRAS1;RAB18;RAB32;GNAI3;RAB6A;IRGM;RHEB;MFN1;RHOA;RAB8B;RHOT1;EEF2;RND1;RAB1A
prerank,tropomyosin binding (GO:0005523),-0.5451561387743838,-1.3604966102206804,0.12354312354312354,0.4791378164294023,1.0,3/16,5.39%,CALD1;S100A6;TMOD2
prerank,potassium ion antiporter activity (GO:0022821),-0.5705886159411181,-1.3589280681429967,0.11486486486486487,0.475135881580648,1.0,4/15,11.27%,SLC24A3;SLC9A9;SLC24A2;SLC9A1
prerank,Toll-like receptor binding (GO:0035325),0.6544170652886682,1.3567379743334385,0.17550274223034734,0.8546156404948166,1.0,2/11,4.28%,DAB2IP;TIRAP
prerank,low-density lipoprotein particle binding (GO:0030169),0.6236988931454606,1.3566771667079829,0.1356521739130435,0.8405710767336259,1.0,4/16,5.29%,PLTP;SCARB1;STAB1;SCARF1
prerank,lipoprotein particle binding (GO:0071813),0.5972602549953694,1.3558713282332933,0.14189189189189189,0.8302660953628246,1.0,5/20,8.23%,PLTP;SCARB1;STAB1;SCARF1;LPL
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4864122663590061,-1.3496795329342541,0.1105121293800539,0.49164337955101545,1.0,11/27,18.74%,SLC41A1;SLC12A2;CNNM2;TUSC3;MAGT1;SLC9B2;CNNM4;MRS2;SLC8A2;SLC4A8;ATP2A3
prerank,carbohydrate kinase activity (GO:0019200),-0.5855388685914912,-1.346938397049461,0.15384615384615385,0.4902990910943014,1.0,4/11,16.08%,GALK2;NAGK;HK2;GALK1
prerank,protein tyrosine kinase binding (GO:1990782),0.4776290305154757,1.340980346509374,0.10599721059972106,0.8816076895003017,1.0,16/71,10.89%,PTPN14;BMPR2;NEDD9;TJP2;PITPNM2;DOCK4;NCK1;GRB14;CEACAM1;DUSP22;ACVR1;CRK;PTPN1;GAS6;EPHA4;CBL
prerank,phosphatase activator activity (GO:0019211),0.6029150898801261,1.3404715732316723,0.16363636363636364,0.8699833243541394,1.0,9/14,27.09%,PPP2R5A;PPP2R5E;PPP2R5B;CALM1;FRS2;PHACTR4;B3GAT3;CALM3;PPP2R5C
prerank,calcium:sodium antiporter activity (GO:0005432),-0.6103866946556068,-1.3348813756588336,0.15124153498871332,0.5137663176941967,1.0,3/10,3.39%,SLC24A3;SLC8A3;SLC8A1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6281267687597679,1.3330793357672703,0.15760869565217392,0.8886545038674671,1.0,6/15,14.79%,SOCS2;PIK3R6;CISH;SLA2;SOCS6;SOCS4
prerank,protein serine/threonine kinase activity (GO:0004674),0.4026034939200427,1.3294698783383583,0.017241379310344827,0.8913493064312735,1.0,87/335,15.78%,PRKCH;RPS6KA5;BMPR2;SNRK;ERN1;ACVRL1;PRKD1;CDK6;DAPK1;NEK7;PIM3;PRKD2;BCR;PTK2B;STK10;PRKD3;MAP4K3;SIK1;CCNK;TAOK2;STK24;STK3;PKN3;PKN2;PAK2;PKN1;RPS6KA3;KALRN;STK4;LMTK2;MARK3;MAP3K9;IKBKB;RPS6KA1;HIPK1;ACVR2A;CDC42BPB;MAPK8;SRPK3;PLK2;MAST2;ULK1;LIMK2;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;TNIK;SGK3;AKT2;NEK6;MAP3K11;AURKC;SLK;BRD4;CDK2;MAPKAPK3;MAPK11;NUAK1;AKT3;MAP3K13;SIK2;STK38;IRAK4;PIM1;RIPK1;MKNK2;RIPK2;TRIO;EIF2AK4;TGFBR2;TOP1;UHMK1;MAPK6;RIOK1;ACVR2B;MAP3K20;MYLK;NRBP1;PRKCG;PAK4;IRAK3;RPS6KA4;MAP4K2;CSNK1G2;CDKL4
prerank,glucose transmembrane transporter activity (GO:0005355),0.5964621568995537,1.3265931384650294,0.16548042704626334,0.8900119994682452,1.0,3/17,6.84%,SLC2A1;MFSD4A;PPBP
prerank,semaphorin receptor binding (GO:0030215),0.5684623428455803,1.3252198279949785,0.15210355987055016,0.8828476757289517,1.0,6/23,10.42%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,peptidoglycan binding (GO:0042834),0.6690005944983969,1.3251742642186375,0.18085106382978725,0.8699524291360506,1.0,2/10,6.35%,NOD1;PGLYRP2
prerank,GTPase binding (GO:0051020),0.4179536966141142,1.325169006993221,0.058682634730538925,0.8573444229166874,1.0,50/195,15.31%,FGD5;FNBP1L;UNC13B;CAV1;LCP1;SPTBN1;TBC1D30;EPS8;RASIP1;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;GNB1;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;ULK1;MYCBP2;IARS1;RUSC2;RASA1;GCC2;EXOC5;YBX3;EXOC4;OCRL;CYRIB;MYO1C;BNIP3;ANKFY1;CYFIP1;PICALM;RILP;CCDC186;EXOC8;EVI5;RABGAP1L;ERC1;TNPO3;STRN3;AIMP1;RAPGEF6;YBX1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6374195449676789,1.324748260593182,0.1801470588235294,0.8468594847775175,1.0,6/12,19.58%,NOD1;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,sequence-specific DNA binding (GO:0043565),0.3924941831635028,1.3234922332277745,0.012307692307692308,0.8405664046620986,1.0,89/590,11.88%,ERG;LEF1;ELK3;FLI1;FOXO1;LHX6;EPAS1;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;SOX13;ELF2;HHEX;NR3C1;HIF1A;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;KLF2;FOXF1;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TET3;TCF7L1;FOXF2;HOXA10;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;HNRNPD;NEUROD1;BACH2;NRL;CREM;CREB1;FOXK1;MYBBP1A;SOX4;MAFB;NFIB;SMG7;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3;TFAP4;POU2F1;CSRNP1;ACD;ATF6;CBFB;SP3;CEBPD;LONP1;PRDM2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5421332595992336,1.3223111779993058,0.16260162601626016,0.8341855229739091,1.0,5/27,6.06%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.4109649778428211,-1.3204909780770984,0.09657320872274143,0.5458514229050527,1.0,16/53,15.93%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC25A12;SLC66A1;SLC7A6;SLC43A1;SLC6A7;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5627195077929461,-1.31981001082845,0.15124153498871332,0.5388847890530213,1.0,7/13,22.92%,GLRB;GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,transcription coregulator binding (GO:0001221),0.4969976837169055,1.3137600772683544,0.1449067431850789,0.8563889828980621,1.0,11/50,9.11%,ESR1;PPARD;ZBTB16;LMO2;AHR;VGLL4;MTF2;TEAD2;CTBP1;NEK6;RPL23
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6116156442546555,1.311910480233268,0.18264014466546113,0.8530597764700744,1.0,3/13,7.41%,PIP5K1B;PIK3C2A;PIK3CG
prerank,clathrin adaptor activity (GO:0035615),0.6202605717142409,1.311292733156008,0.1813380281690141,0.8439678596167167,1.0,4/15,7.58%,HIP1;HIP1R;AP2B1;AP2A1
prerank,"DNA binding, bending (GO:0008301)",0.6308823362639995,1.3095528933954022,0.1869328493647913,0.8396981370535552,1.0,2/14,2.25%,LEF1;HHEX
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5963354741190581,-1.3082528156464448,0.15766738660907129,0.5621915717301527,1.0,6/10,22.92%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,GTP binding (GO:0005525),0.4196046314066926,1.3074274031783397,0.06880189798339265,0.8373486822574793,1.0,37/172,13.81%,RAB27A;TGM2;GCH1;INSR;GBP5;MFHAS1;GBP4;RAP1B;RHOJ;RALB;GBP7;NRAS;KRAS;RAC1;ARL4A;GNAT1;RAP1A;RHOBTB1;RAB2A;DYNC1LI1;RAB38;TUBE1;ARL5A;NUDT16;ARL8B;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB31;RAB5A;RAB7A;EIF2B2;ATL1;GBP3
prerank,protease binding (GO:0002020),-0.3640533666723483,-1.304449381387235,0.06751054852320675,0.5633469852656068,1.0,24/99,8.12%,COL1A2;COL3A1;COL1A1;TIMP3;PRKN;BCL2;TIMP2;CCBE1;SLC2A13;F3;DPP4;FAP;ATP9A;ADAMTSL4;NTRK2;SELENOS;ITGAV;PSAP;LDLR;STIM1;ANXA2;AMFR;ECM1;BDKRB2
prerank,general transcription initiation factor binding (GO:0140296),0.5496943311462837,1.3027902065944572,0.19218241042345277,0.845521316211688,1.0,7/25,12.88%,ESR1;AHR;HHEX;TAF1B;YEATS2;RELA;GTF2A2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6453154623471724,1.2997329462795273,0.2038095238095238,0.8462942460740788,1.0,1/10,0.09%,SHANK3
prerank,anion:anion antiporter activity (GO:0015301),-0.5180831304355212,-1.2991203883770115,0.14081145584725538,0.5690887941062427,1.0,7/17,19.24%,SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC19A1;SLC26A6;SLC25A4
prerank,double-stranded DNA binding (GO:0003690),0.3854989826586412,1.2988414787810059,0.016614745586708203,0.8390617640267837,1.0,68/531,10.33%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;ELF2;AIM2;NR3C1;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;KLF2;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TCF7L1;HOXA10;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;NEUROD1;BACH2;NRL;CREM;CREB1;FOXK1;SOX4;CGAS;NFIB;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3
prerank,ephrin receptor binding (GO:0046875),0.5746695977563178,1.2973696167712838,0.18493150684931506,0.8342684522435158,1.0,9/21,11.22%,ANKS1A;LYN;EFNA1;FYN;PIK3CG;CRK;PTPN1;CBL;ANKS1B
prerank,transcription cis-regulatory region binding (GO:0000976),0.3910504160085527,1.2960776427152434,0.024442082890541977,0.828633307240484,1.0,56/406,11.88%,LEF1;ELK3;FLI1;LHX6;EPAS1;DACH1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;ETV6;IRF2;FOXP1;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;RREB1;SOX17;ACTN4;ZFP57;SOX18;TCF12;FOSL2;ZBTB46;FOXF1;XBP1;FOXF2;TCF7L2;ATMIN;KLF10;NR1I3;FOXA3;ASCL4;FOXN2;HOXD8;TCF3;NFKB1;CREM;FOXK1;TCF15;SOX4;FOXN3;ZBTB10;TFAP4;GABPB1;RB1;ATF6;SP3;SNAPC3;LONP1;PRDM2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3819602054329532,1.2940011294306129,0.01331967213114754,0.8273783288313726,1.0,77/597,10.33%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;SMARCA2;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;SOX13;ELF2;HHEX;TAL1;STAT3;NR3C1;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;KLF2;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TCF7L1;HOXA10;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;ATMIN;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;MCM10;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;NFKB1;NEUROD1;POLA1;BACH2;NRL;CREM;CREB1;FOXK1;SOX4;NFIB;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6281806225982516,1.2932127334846069,0.18265682656826568,0.8204074171806798,1.0,7/11,15.69%,DAB2IP;SASH1;TCF3;MAP3K11;STK38;TRAF6;MAP4K2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.5169015086130887,1.2910714252472761,0.17580645161290323,0.8188221440504163,1.0,10/33,16.32%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A;SIAH1;TRAF6;ARIH2;RNF5;UBE3D
prerank,acid-thiol ligase activity (GO:0016878),-0.530779316271545,-1.2907458815115629,0.1734475374732334,0.5841575898574736,1.0,4/13,14.94%,ACSL1;AASDH;AACS;ACSS2
prerank,protein tyrosine kinase activity (GO:0004713),0.43394287632168443,1.2903254670140265,0.10732323232323232,0.8120549795149088,1.0,22/108,7.46%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;PEAK1;LYN;PTK2B;YES1;FYN;SRMS;FLT4;LMTK2;JAK3;HIPK1;RET;DYRK1A;BMX;LCK;JAK1;PTK2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.4794255211004871,-1.2902361630337524,0.14617169373549885,0.5768080882906137,1.0,10/20,28.15%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3
prerank,GDP binding (GO:0019003),0.4641310416347306,1.2858518775465517,0.1394700139470014,0.8185862413978879,1.0,20/63,16.86%,RAB27A;RAP1B;RALB;NRAS;KRAS;GNAT1;RAP1A;RAB2A;DYNC1LI1;ARL8B;RAB12;RAB11B;RAB31;RAB5A;RAB7A;RAB5B;RAB18;GNAI3;RHEB;RAB8B
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5245992592262896,1.2856934587607558,0.14424635332252836,0.8099965628345333,1.0,10/30,16.67%,RPS6KA3;RPS6KA1;SERPINB9;XIAP;GAS6;CARD16;TNFAIP8;BIRC3;CAST;BIRC2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5842400693437102,-1.2842693148090587,0.19389978213507625,0.5860422416349246,1.0,3/10,9.72%,DSE;RENBP;DSEL
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3760788193354787,1.2838266469712292,0.01015228426395939,0.8073248257272498,1.0,97/730,10.33%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;FOSL2;MAFF;KDM6A;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;KLF13;LYL1;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;TRIM24;FOXK1;CHD2;TCF15;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3
prerank,LRR domain binding (GO:0030275),-0.5251814437095029,-1.2828126171916188,0.16904761904761906,0.5812015667234239,1.0,5/14,12.74%,ROBO1;PAWR;LRRFIP2;PMF1;ZXDC
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.382355135018,1.2821836026412519,0.024210526315789474,0.8046903460837888,1.0,97/431,15.69%,RPS6KA5;RAB27A;TGM2;SNRK;ERN1;ACVRL1;GCH1;CDK6;INSR;DAPK1;MYH9;PEAK1;GBP5;PRAG1;MFHAS1;GBP4;MAP4K3;SIK1;RAP1B;STK3;RHOJ;STK4;LMTK2;RALB;GBP7;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;SIK3;ACVR1;TSSK6;NRAS;KRAS;RAC1;ARL4A;STK26;GNAT1;MTREX;MLKL;RAP1A;RHOBTB1;TRIP13;RAB2A;DYNC1LI1;RAB38;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TUBE1;ARL5A;NUDT16;ARL8B;NMUR2;TWF2;ATP7B;PSMA6;DRG2;AKT3;SIK2;STK38;RNF112;LONP1;PIM1;ABCD1;RAB26;MKNK2;RAB11B;RHOB;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;RAB31;RAB5A;MTPAP;RAB7A;ABCG1;EIF2B2;ATL1;GBP3;MAP3K20;RAB32;PMVK;PNPLA8;RAB6A;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.37586859299986664,1.28195138284232,0.008130081300813009,0.7967115175288807,1.0,99/731,10.71%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;FOSL2;MAFF;KDM6A;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;KLF13;LYL1;FOXN2;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;FOXK1;CHD2;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3;FOXN3;TFAP4;POU2F1
prerank,frizzled binding (GO:0005109),-0.43529679013739087,-1.279524612245439,0.12813370473537605,0.5818999612252812,1.0,13/34,17.66%,WNT4;RNF43;WNT6;WNT9A;RYK;LRP6;SFRP1;FZD1;WNT16;FZD7;WNT11;DVL1;MYOC
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4949466483636811,1.2785469867449852,0.16012084592145015,0.8014969682671941,1.0,11/42,11.11%,SHE;YES1;FBXW7;PLCG2;BCAR3;LCK;RASA1;NEDD4;SAMSN1;CRK;ABL2
prerank,nuclear receptor binding (GO:0016922),0.4307162635641764,1.272816090056352,0.11948051948051948,0.8133702763026244,1.0,22/111,12.23%,LEF1;TACC1;ESR1;FOXP1;HIF1A;KDM3A;ACTN4;DDX54;PKN1;NCOA1;TRIM68;TCF7L2;JMJD1C;ARID1A;KDM4C;NRIP1;CNOT1;SMARCE1;MMS19;DCAF1;OASL;ASXL1
prerank,guanyl ribonucleotide binding (GO:0032561),0.4026276594300347,1.2683294090503892,0.08333333333333333,0.8204916067735327,1.0,52/196,17.63%,RAB27A;TGM2;GCH1;INSR;PDE2A;GBP5;MFHAS1;GBP4;CNGB1;RAP1B;RHOJ;RALB;GBP7;RAPGEF2;NRAS;KRAS;RAC1;ARL4A;GNAT1;RAP1A;RHOBTB1;RAB2A;DYNC1LI1;RAB38;TUBE1;ARL5A;NUDT16;ARL8B;RAB12;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB31;RAB5A;RAB7A;EIF2B2;ATL1;GBP3;RAB5B;RAB18;RAB32;GNAI3;RAB6A;RHEB;RHOA;RAB8B;RHOT1;ADSS2;RND1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.46964551328659326,1.2652112350932616,0.1531791907514451,0.8229795963008422,1.0,14/54,15.26%,HDAC9;ACER2;TGM2;GLS2;GLS;ASAH2;SIRT5;PM20D2;HINT1;MIER1;SIRT6;ACR;ASAH1;FAAH
prerank,E-box binding (GO:0070888),0.49801292338956504,1.2616980713211143,0.2009132420091324,0.827499350611868,1.0,8/34,12.40%,AHR;TAL1;TCF4;TCF3;NEUROD1;TCF15;TFAP4;MAX
prerank,retinoid X receptor binding (GO:0046965),0.6175124646660369,1.2594017663376456,0.23306772908366533,0.8273092331239422,1.0,2/11,9.89%,TACC1;NRIP1
prerank,ligand-gated cation channel activity (GO:0099094),-0.36360247054026285,-1.2584432252681863,0.12121212121212122,0.6314097067866682,1.0,22/75,18.62%,GRIN3A;GRIA2;P2RX4;GRIA3;GRIA1;KCNJ2;KCNJ13;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;KCNJ10;GRIN2D;KCNN2;CCDC51;KCNJ8;KCNJ15;KCNJ6;CHRNA7;KCNN3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.559646554314735,1.2542596094353935,0.23550087873462214,0.8371760539819715,1.0,2/16,3.22%,CD38;BST1
prerank,protein phosphatase 1 binding (GO:0008157),0.5453499440634348,1.2500208767366807,0.22749590834697217,0.8441194442695251,1.0,4/21,8.48%,PPP1R16B;KCNQ1;PPP1R9B;SHOC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.565830514036743,-1.2492482288769915,0.22289156626506024,0.6497339623454397,1.0,1/10,0.52%,DPYSL3
prerank,inward rectifier potassium channel activity (GO:0005242),-0.46396592737142855,-1.2481929737426234,0.1957040572792363,0.6433331385744714,1.0,9/24,18.62%,ABCC9;KCNJ2;KCNJ13;KCNJ10;KCNN2;KCNJ8;KCNJ15;KCNJ6;KCNN3
prerank,ribonuclease activity (GO:0004540),0.4618332855281545,1.2473652687571852,0.15565345080763582,0.8450525744631725,1.0,14/56,14.45%,ERN1;SAMHD1;CNOT6;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4;KHNYN;DICER1;INTS11;EXOSC1;CNOT7;ZC3H12C
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.6152014691373242,1.244424856689534,0.2586520947176685,0.8475239980705528,1.0,4/11,14.62%,SGMS1;DPAGT1;GNPTAB;PIGF
prerank,transcription coactivator binding (GO:0001223),0.5485917156033047,1.243435412825759,0.22366288492706646,0.842961390975231,1.0,6/20,9.11%,ESR1;PPARD;AHR;VGLL4;TEAD2;RPL23
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4729169781048912,1.2416236571820525,0.19407407407407407,0.841038057086751,1.0,1/44,0.03%,MECOM
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5252171918853586,-1.2411666631477947,0.2385542168674699,0.6547069364828186,1.0,3/14,2.94%,ENPP1;FHIT;NUDT4
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.40881372102223,-1.240177200576331,0.1419753086419753,0.6487868682952049,1.0,8/38,10.33%,SERPING1;TFPI;SERPINH1;SERPINE2;SERPIND1;ANXA2;SERPINF1;SERPINE1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.36249453583104513,1.2396963630212274,0.023185483870967742,0.839725836101096,1.0,106/830,10.71%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;LHX6;EPAS1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;ACTN4;ZFP57;SOX18;TCF12;FOSL2;MAFF;KDM6A;ZBTB46;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;ASCL4;KLF13;LYL1;HOXD8;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;FOXK1;CHD2;TCF15;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3;ZBTB10;TFAP4;POU2F1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.383172729334102,1.2359567240315148,0.09111617312072894,0.8444000395817528,1.0,59/248,17.63%,DNM3;RAB27A;GNAQ;GCH1;MYH9;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;KIF26A;GPN3;RHOJ;RALB;SMCHD1;GBP7;GNAI2;ABCA3;NRAS;KRAS;RAC1;GNAT1;RAP1A;RHOBTB1;RAB2A;GNA12;RAB38;MYO1E;ARL8B;DRG2;RNF112;MYL6B;ABCD1;RAB11B;RAB43;RHOB;HBS1L;GNA13;RAB31;RAB5A;TOR3A;RAB7A;ATL1;GBP3;RAB5B;NKIRAS1;RAB18;RAB32;GNAI3;RAB6A;IRGM;RHEB;MFN1;RHOA;RAB8B;RHOT1;EEF2;RND1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.43485298974399716,1.2326802650939737,0.18132611637347767,0.8481786636926415,1.0,10/71,6.07%,PTPRB;PTPRG;PTPN14;PTPRM;PTPN12;PTPRJ;PTP4A2;PTPRK;MTMR6;DUSP22
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5044654059823207,-1.2311400308939409,0.21654501216545013,0.6656129466745576,1.0,7/16,18.09%,SLC26A7;SLC26A2;SLC26A6;SLC1A1;CLCN7;CFTR;SLC4A8
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5545966476944267,-1.2248683155669355,0.22811059907834103,0.6760054989601325,1.0,2/11,5.79%,SLC22A4;SLC25A47
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4408250601442065,1.2247211193407255,0.19943422913719944,0.8686833240903981,1.0,10/60,5.59%,NRP2;TEK;FLT1;KDR;TIE1;EPHB4;INSR;FLT4;LMTK2;RET
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.48703068888950934,1.2216856481002558,0.23444976076555024,0.8721302710006242,1.0,12/35,17.69%,FOXP1;NR3C1;H3-3A;KLF10;TAF1B;RRN3;POU2F1;SNAPC3;RELA;NPM1;PIH1D1;STAT1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4241125011675722,1.2185945937423739,0.17866323907455012,0.875203557031768,1.0,19/85,15.84%,PLA2G4A;ABHD2;PGAP1;LIPE;BCHE;ENPP2;PLA2G2D;CA1;PON2;LPL;PLAAT3;PTRH1;GDPD1;PNPLA2;PNPLA6;FAAH;NDST3;CA2;ESD
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.43698667687252424,-1.2173655880003846,0.18798955613577023,0.6897763991211063,1.0,11/27,19.95%,SLC8A3;SLC41A1;SLC9A9;SLC8A1;SLC9A1;SLC9B2;CNNM4;SLC8A2;SLC4A8;SLC8B1;SLC9A8
prerank,ubiquitin-dependent protein binding (GO:0140036),0.6019552739556939,1.2146503511610136,0.27052238805970147,0.8807631241997439,1.0,3/10,10.68%,ANKRD13A;USP15;FAN1
prerank,alpha-actinin binding (GO:0051393),-0.4445471821600974,-1.212583447636,0.18251928020565553,0.6945337462759091,1.0,5/24,4.17%,CACNA1C;CACNA1D;DAG1;PALLD;PDLIM7
prerank,SUMO transferase activity (GO:0019789),-0.47415591302438725,-1.2075629864930781,0.23645320197044334,0.7010372237301279,1.0,6/16,19.11%,HDAC4;MDM2;PIAS1;PIAS3;TRIM28;CBX4
prerank,potassium channel regulator activity (GO:0015459),-0.3766220213200894,-1.2067944245631212,0.16216216216216217,0.6945231906327939,1.0,11/49,9.95%,KCNIP3;KCNIP4;WNK4;ABCC9;DLG1;SLC5A3;KCNMB2;KCNS3;KCNAB1;DPP6;WNK1
prerank,DNA-binding transcription factor binding (GO:0140297),0.38335601442852774,1.205192269689001,0.15133876600698487,0.9067172552372276,1.0,36/189,14.16%,HDAC9;LDB2;PPARD;MEF2C;LMO2;CRTC1;NFATC1;HHEX;TAL1;STAT3;HDAC7;TLE4;SIK1;PITX1;TCF12;GTF2I;EIF4E;TCF7L2;FBP1;TCF3;NEUROD1;CTBP1;CREM;CREB1;NEK6;ZFPM1;MAD2L2;USF2;SPEN;RB1;MIER1;RELA;PTMA;MEF2A;NPM1;MEF2D
prerank,GABA-A receptor activity (GO:0004890),-0.4745485798872091,-1.2047955403491968,0.2337962962962963,0.6920899573478093,1.0,8/18,22.92%,GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5640392132272438,1.202501882795958,0.2600732600732601,0.908857406735495,1.0,7/14,17.97%,MINDY1;MINDY2;USP15;ATXN3;YOD1;DESI2;USP7
prerank,cytokine activity (GO:0005125),-0.3193471958207415,-1.2001052536555346,0.09424083769633508,0.6980598625599723,1.0,23/131,14.74%,BMP6;IL34;WNT4;BMP5;BMP7;IL18;WNT6;BMP4;FGF2;CXCL16;WNT9A;IL16;TNFRSF11B;VEGFA;CXCL12;INHBA;TGFB3;TGFB2;WNT16;GDF11;GDF1;IL17D;WNT11
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.44439303179419215,1.1996195870227082,0.23285714285714285,0.9110829725195799,1.0,12/49,10.38%,MINDY1;BABAM2;RNF169;MINDY2;UBL7;BRCC3;ZRANB1;IKBKG;ZFAND2B;RAD18;RAD23A;TNIP1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5212645729165662,-1.1979531401255068,0.26597938144329897,0.6963025535922007,1.0,2/11,2.65%,EGFR;MAP3K5
prerank,kinase binding (GO:0019900),0.357909016230113,1.1968587252494578,0.10436634717784878,0.913330599067514,1.0,94/435,14.29%,FRMD5;CAV1;ESR1;UTRN;SLC12A7;PDE8A;ACVRL1;SMAD1;PLCG1;PPP2R5A;IQGAP1;DAB2IP;ADAM10;FAS;STAT3;NR3C1;HDAC7;TRIM14;HIF1A;MSN;PTPRJ;SIK1;CCNK;TTC28;PLCG2;CAV2;PPP1R12A;PAK2;RPS19;PIK3IP1;IKBKB;CEACAM1;GHR;PTPRK;TRIM68;TCF7L2;ATP1A4;LRBA;AURKA;RPS7;SKAP1;IFNAR2;RAC1;SASH1;CDKN1B;TRIB3;BCAR3;GNAT1;HNRNPA0;LCK;PTK2;AP2A1;GRB7;STX1A;TRPV4;RHOBTB1;CASP1;POLA1;WWC2;RPTOR;NEK6;ARHGEF7;LLGL1;CRK;RELB;PTPN1;RICTOR;MAP2K3;BCL2L1;RAD23A;PRKAB1;BTG1;RB1;MAP3K13;IRAK4;PEBP1;CARD16;RHOB;RELA;ADIPOR1;CEP68;ZFP36;MYH6;WARS1;HSP90AB1;PFKL;CDC25C;LRRC14;GSKIP;RPS6;NPM1;TRAF6;BCL2L14;APC
prerank,manganese ion binding (GO:0030145),-0.37997354736193323,-1.1962948350274265,0.18541033434650456,0.6930447277786648,1.0,8/48,8.75%,MPPED2;ADCY2;LARGE1;ME1;FAM20C;NEK4;PPM1M;TDP2
prerank,G protein-coupled receptor activity (GO:0004930),0.36863208694763255,1.1913370685381754,0.1506849315068493,0.9249195185367373,1.0,15/239,6.51%,ADGRG6;ADGRL4;CALCRL;CYSLTR1;ADGRL2;NPR1;S1PR1;ADGRG3;ADGRE5;ADGRG1;ADRB1;CX3CR1;HCRTR1;MCHR1;OPN4
prerank,ATP binding (GO:0005524),0.3649008950726819,1.1912435634880891,0.1484814398200225,0.9172806511198337,1.0,59/266,15.69%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PRAG1;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;SIK3;ACVR1;TSSK6;STK26;MTREX;MLKL;TRIP13;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TWF2;ATP7B;AKT3;SIK2;STK38;LONP1;PIM1;ABCD1;MKNK2;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;MTPAP;ABCG1;EIF2B2;MAP3K20;PMVK;PNPLA8;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.47420319801521926,1.1880919160642995,0.26409495548961426,0.9206935095228792,1.0,15/34,22.17%,CNOT6;PAN3;CNOT6L;ISG20;ANGEL2;CNOT1;REXO2;CNOT2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,chemorepellent activity (GO:0045499),0.49583237077371284,1.1866836436627288,0.27704918032786885,0.9181029159116969,1.0,3/25,1.68%,SEMA6A;SEMA5B;SEMA7A
prerank,metalloaminopeptidase activity (GO:0070006),-0.48370411334476093,-1.186164904487583,0.26339285714285715,0.7141167028864622,1.0,4/16,7.32%,MMP14;MMP16;NPEPPS;ENPEP
prerank,hexosyltransferase activity (GO:0016758),0.39733503697431927,1.1835379677126296,0.21680216802168023,0.9216940214090718,1.0,13/101,8.78%,CSGALNACT1;TMTC2;LFNG;MGAT4A;GBE1;MFNG;B3GNT3;B4GALT4;MTAP;B3GNT4;B4GALT5;B4GAT1;B3GNT6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3742310051795914,1.1811120479785755,0.17927823050058206,0.922397387054568,1.0,18/188,6.46%,FLI1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;SOX13;HHEX;TAL1;STAT3;SOX17;SOX18;TCF12;LIN54;TCF7L2;ATMIN;FOXA3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5685944618117343,1.1808183527441203,0.3058608058608059,0.9158105413404419,1.0,1/11,3.14%,CNGB1
prerank,cholesterol transfer activity (GO:0120020),0.5250287317049992,1.1794887897928883,0.2733446519524618,0.9130594153472299,1.0,2/16,3.09%,PLTP;STARD5
prerank,acylglycerol lipase activity (GO:0047372),0.5791480711159815,1.1792165483880688,0.304029304029304,0.9065746846801186,1.0,2/11,3.88%,ABHD2;LIPE
prerank,protein homodimerization activity (GO:0042803),0.3456950337516914,1.178057119705665,0.09259259259259259,0.9031559239094004,1.0,88/590,10.76%,ABCG2;PECAM1;ZHX3;NOD1;ST6GAL1;TBX1;CADM1;RBPMS;ZBTB16;ERN1;F11R;GCH1;B2M;AHR;RASIP1;LRRFIP1;PDGFB;HIP1;HIP1R;MYH9;IL6R;DAB2IP;FZD4;HHEX;PDE2A;ADAM10;STAT3;GBP5;TPST2;GBP4;SRGAP2;STK10;TRIM14;TPD52;KLHL7;TPD52L1;ACTN4;TBC1D22A;FLT4;CAV2;CAT;ABCB7;ACTN1;SPPL2A;STK4;SMCHD1;MAP3K9;IKBKB;CEACAM1;GHR;GREM1;TRIM68;MTHFD1L;BOK;CCDC88A;DROSHA;MID2;TOX3;ACVR1;EEA1;SH3GLB1;STK26;SYNE1;PDGFC;TCF3;PKD2;LPL;CITED1;GSTA4;ANG;MAP3K11;SLK;DEFA6;CHMP4B;CHMP4A;NUDT16;CEP57;IKBKG;CSF1;IZUMO1;BCL2L1;INPP5F;USF2;CYP2R1;TFAP4;GGCT;SCARB2;BNIP3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6022856962346105,1.1774304397301458,0.298372513562387,0.8979289401985684,1.0,2/10,1.65%,SLCO2B1;SLCO2A1
prerank,sterol transfer activity (GO:0120015),0.5188706157234348,1.1737830637222515,0.2799325463743676,0.9037078939942019,1.0,2/17,3.09%,PLTP;STARD5
prerank,endopeptidase activity (GO:0004175),-0.2797749135842364,-1.1714170609168981,0.041237113402061855,0.750428973183048,1.0,40/257,12.48%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;F3;RHBDL3;DPP4;HTRA3;PCSK5;ADAMTSL1;FAP;MMP14;ADAMTS17;ADAMTSL4;MMP16;USP24;USP11;ADAM19;ADAMTS15;TASP1;ADAMTS1;ADAM33;KLK2;PLAT;USP13;RHBDF1;SFRP1;MMP2;USP49;USP33;ADAMTS14;USP10;ADAM9;MMP11;KDM8
prerank,voltage-gated cation channel activity (GO:0022843),-0.32647648585696765,-1.1671043231776062,0.1759656652360515,0.7545489795198984,1.0,18/97,10.69%,CACNA1C;CACNA2D3;CACNA2D1;KCNB2;CACNA1D;GRIN3A;KCNMA1;KCNQ3;KCND2;KCND3;CACNB2;ITGAV;KCNC2;KCNS3;KCNQ4;CACNB1;KCNQ5;GRIN2A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5316069726024647,-1.164409916724591,0.30357142857142855,0.7543399366534368,1.0,4/10,13.10%,B3GALT1;B4GALT6;B3GALT5;B4GALT7
prerank,ion channel inhibitor activity (GO:0008200),0.4661797561918371,1.1606832308028419,0.2688679245283019,0.9426824740881069,1.0,10/35,12.70%,NEDD4L;FKBP1A;STX7;RASA1;STX1A;NEDD4;MCUB;VAMP8;STX8;RACK1
prerank,zinc ion binding (GO:0008270),0.3539958444649362,1.1603600706321069,0.16740088105726872,0.9362118484472408,1.0,59/293,17.13%,MYRIP;SHANK3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;TES;TET3;ENPP2;ASAH2;MYCBP2;PAM;EEA1;ADAMDEC1;SIRT5;ERAP1;KDM4C;PRIMPOL;ZNF2;TRIM24;PGGT1B;PTPN1;AFM;SIAH1;RC3H1;RPS27;ZMYND11;PITRM1;RNF112;PRDM2;ADH1A;SIRT6;TET2;SORD;TMEM163;AOC1;IFIH1;ACR;RPS29;S100A9;MSRB2;KAT6A;ARIH2;ACE;RNF5;CA2;ZFPL1;TAB3;CHORDC1;BIRC2;KDM5C;APIP;KDM4A;ZNF8
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.536976330159777,1.1603251402946109,0.3022452504317789,0.9290623931669826,1.0,6/18,14.79%,SOCS2;PIK3R6;CISH;SLA2;SOCS6;SOCS4
prerank,phosphotyrosine residue binding (GO:0001784),0.45949792912872833,1.1602871634967113,0.26697530864197533,0.9220229295064205,1.0,9/37,11.11%,SHE;YES1;PLCG2;BCAR3;LCK;RASA1;SAMSN1;CRK;ABL2
prerank,cGMP binding (GO:0030553),0.5579124223018723,1.1589455738759629,0.3208955223880597,0.9194969516762697,1.0,3/11,6.11%,PDE2A;CNGB1;RAPGEF2
prerank,DNA binding (GO:0003677),0.3410942874634955,1.158751980547996,0.11483739837398374,0.9131568047130273,1.0,100/694,13.44%,MECOM;ERG;LEF1;FLI1;FOXO1;EPAS1;PBX1;TBX1;SMARCA2;APP;PPARD;TSHZ2;ZBTB16;NR5A2;AHR;ZIC3;LRRFIP1;IRF2;SOX13;HHEX;STAT3;AIM2;SAMHD1;HIF1A;ARID3B;TSHZ1;RPS15;HMBOX1;MAFF;KLF2;ZNF292;FOXF1;ELK4;FOXL2;XBP1;TCF7L1;FOXF2;MTF2;TCF7L2;TCF4;LIN9;CNBP;ETS2;JUNB;LYL1;MCM10;SPDEF;RPA1;TCF3;ARID1A;NEUROD1;POLA1;NRL;CDT1;CREM;SMARCA5;EZH1;TAF4B;ANG;MYBBP1A;SUB1;APLP2;CHD2;RAD51D;CGAS;MAFB;BRIP1;RNF4;NFIB;MEIOB;RAD18;RAD23A;KLF12;USF2;GLYR1;TFAP4;FAN1;POU2F1;CSRNP1;RPS27;ZMYND11;ATF6;UNG;CBFB;SNAPC3;LONP1;MCM9;PRDM2;OASL;RELA;MAX;WDR76;RPL6;SLTM;ERCC4;TOP1;IMPDH1;ZBTB6;ACR;ESRRB
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.43912996941573407,-1.1584446620435351,0.26941747572815533,0.7640265391409246,1.0,5/21,18.44%,GRM5;GRIA1;GRM1;CHRFAM7A;CHRNA7
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42099903277078277,1.1584204538031124,0.26200873362445415,0.9074058327532061,1.0,12/60,6.27%,TEK;FLT1;KDR;TIE1;EPHB4;ACVRL1;INSR;FLT4;LMTK2;ACVR2A;RET;ACVR1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.35197605813956456,-1.1576789785602952,0.18566775244299674,0.757824184346092,1.0,12/55,9.51%,SLC24A3;CACNA1D;PKD1;MCU;CACNB2;TRPC3;ANXA2;ANXA6;TRPC1;ATP2A2;RYR2;SLC24A2
prerank,store-operated calcium channel activity (GO:0015279),-0.5162810636570682,-1.1569501340278725,0.30892448512585813,0.7516580406965963,1.0,6/10,13.68%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5;ORAI2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5657918544307838,1.1562699613104814,0.32149532710280376,0.9077116036074534,1.0,2/10,10.68%,ANKRD13A;FAN1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3958996114592216,1.155565363507578,0.23246753246753246,0.9034646348033557,1.0,22/100,15.30%,CERT1;PLA2G4A;ARAP3;PARD3;HIP1;HIP1R;IQGAP1;DAB2IP;DENND1B;TECPR1;PLEKHA5;SNX3;PLEKHA8;SNX24;ARAP2;ANKFY1;SNX11;KIF16B;CYTH3;SNX13;ATG2A;ATG2B
prerank,transcription corepressor binding (GO:0001222),0.47572585156540736,1.1459963855227995,0.3056426332288401,0.9287687940565281,1.0,6/27,11.13%,ESR1;ZBTB16;MTF2;CTBP1;NEK6;CNOT2
prerank,Tat protein binding (GO:0030957),0.5707711102338868,1.1437821831595214,0.32181818181818184,0.9296819062032842,1.0,5/10,16.04%,DLL1;DNAJA1;GABARAPL1;NPM1;CTDP1
prerank,serine-type peptidase activity (GO:0008236),-0.31724679857418464,-1.1433732658374163,0.167420814479638,0.7835111550279971,1.0,12/96,9.22%,F3;RHBDL3;DPP4;HTRA3;PCSK5;FAP;HTRA1;NAALAD2;KLK2;PLAT;RHBDF1;MMP2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.549258410758129,1.142811181196571,0.33575317604355714,0.925901689538514,1.0,5/12,21.47%,SPPL2A;PSEN1;SPPL3;DDI2;NAPSA
prerank,small GTPase binding (GO:0031267),0.3640427317252304,1.142694545753427,0.23579201934703747,0.9196844067115276,1.0,35/170,13.05%,FGD5;UNC13B;CAV1;TBC1D30;EPS8;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;ULK1;MYCBP2;RUSC2;GCC2;EXOC5;YBX3;EXOC4;OCRL;CYRIB;MYO1C;ANKFY1;CYFIP1;PICALM;RILP;CCDC186;EXOC8;EVI5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5094043933662873,1.1421147648981822,0.32246998284734135,0.914920721047597,1.0,5/18,6.27%,BMPR2;ENG;ACVRL1;ACVR2A;ACVR1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.453258118082468,1.1414214968503174,0.29675425038639874,0.910775114587069,1.0,11/38,15.30%,PLA2G4A;PARD3;HIP1;DAB2IP;TECPR1;PLEKHA5;SNX3;KIF16B;SNX13;ATG2A;ATG2B
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5127449187077301,-1.1411598229681923,0.31096196868008946,0.781921906066181,1.0,3/11,4.91%,KCNK2;KCND2;KCND3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.46428049663348625,-1.1398621499620085,0.30786516853932583,0.7772780147343932,1.0,8/15,10.63%,HS3ST3A1;HS3ST3B1;HS6ST3;HS2ST1;HS3ST4;HS6ST2;HS3ST5;HS6ST1
prerank,phosphate ion binding (GO:0042301),0.573542176923016,1.1396025583493714,0.32710280373831774,0.9104232181358759,1.0,4/10,19.80%,PDE2A;RELA;ADSS2;PNP
prerank,dynactin binding (GO:0034452),-0.4917181770564906,-1.1390581769208512,0.29128440366972475,0.771880250743182,1.0,5/12,13.81%,BICD1;SNX6;SNX5;HTT;BICD2
prerank,hormone receptor binding (GO:0051427),0.5284480038706236,1.1387593349409812,0.33559322033898303,0.9070003213134131,1.0,2/14,7.26%,SOCS2;JAK1
prerank,myosin binding (GO:0017022),0.41829996744022474,1.1368644513055903,0.28674351585014407,0.9073014956771596,1.0,9/55,9.05%,MYRIP;SHROOM4;RAB11A;SHROOM1;NKD2;LMTK2;SPATA6;LLGL1;USH2A
prerank,potassium channel activity (GO:0005267),-0.3179456691645408,-1.1365694219683242,0.17073170731707318,0.7713954501664914,1.0,22/89,14.45%,KCNK2;KCNB2;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNQ4;GRIK4;TMEM38A;KCNQ5;GRIK2;GRIK5;KCNA6;GRIK1;KCNT1;KCNN2;CCDC51
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4648712221540344,-1.1362216547716293,0.3080357142857143,0.7646042209051127,1.0,5/14,21.59%,NOX4;AIFM1;CYBB;NOX1;NCF2
prerank,solute:sodium symporter activity (GO:0015370),-0.4048724342580145,-1.1361820193342955,0.2882205513784461,0.7569725952820175,1.0,6/27,18.09%,SLC4A10;SLC5A3;SLC20A1;SLC5A6;SLC5A11;SLC4A8
prerank,glycine binding (GO:0016594),-0.49557413732921785,-1.1361654830043293,0.32397408207343414,0.749443195036836,1.0,2/11,4.04%,GRIN3A;GLRB
prerank,protein phosphatase regulator activity (GO:0019888),0.4219937871720451,1.1348418175411747,0.30014224751066854,0.9077632305989698,1.0,21/53,21.63%,PPP1R16B;PPP2R5A;PPP1R2;PPP1R9B;LMTK2;PPP2R2C;PPP2R5E;PPP2R5B;SHOC2;PPP2R3A;PPP2R2D;MGAT5;RCAN1;PPP1R7;CALM1;PPP2R2A;EIF2AK2;PPP2R1A;PPP2R1B;PPP4R1;PHACTR4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4978081038975267,-1.1345599386041743,0.31786542923433875,0.7462751315845039,1.0,5/11,13.02%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3626062403511664,1.1317889118040019,0.23742690058479532,0.9113676805951361,1.0,34/181,12.89%,LDB2;TACC1;PPARD;LMO2;NFATC1;TAL1;STAT3;HIF1A;NFKBIA;PITX1;ACTN4;GTF2I;NCOA1;DLL1;DTX3L;TCF7L2;FBP1;DNAJA1;TCF3;ARID1A;NEUROD1;CREB1;TAF4B;ZFPM1;NRIP1;MAD2L2;PSMA6;SMARCE1;SPEN;RB1;GABARAPL1;MIER1;RELA;RNF25
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5412955568442632,1.1275538797593674,0.3471223021582734,0.919235412474849,1.0,4/12,17.69%,TRAF1;BABAM2;TRAF6;STAT1
prerank,ubiquitin protein ligase binding (GO:0031625),0.34762937743983024,1.1271745975070715,0.23562570462232243,0.9142683014346603,1.0,71/254,19.83%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;PRKAR2B;CASP8;TRAF1;NKD2;TMBIM6;RALB;SMAD7;HERC2;PRR5L;CD40;TRIB3;DNAJA1;ATXN3;SNCAIP;ARRB1;JAK1;UBE2G1;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC4R;MC1R;RB1;CUL1;RIPK1;GABARAPL1;RELA;PA2G4;HSP90AB1;ASB4;TRIB1;TXNIP;NDUFS2;UBE2K;TRAF6;APC;MID1;UBXN1;BAG4;CHEK2;RPL11;KDM4A;NEDD8;CUL3;YOD1;BAG1;USP7;RNF40;PRKACB;CUL2;USP25;BCL10;TSG101;SMAD2;GPI;NLK
prerank,adenyl ribonucleotide binding (GO:0032559),0.34286066159480466,1.12259462790457,0.2334455667789001,0.9225853415132672,1.0,63/291,15.69%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PDE2A;PRAG1;PDE4D;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;RAPGEF2;SIK3;ACVR1;FBP1;TSSK6;STK26;MTREX;MLKL;TRIP13;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TWF2;ATP7B;AKT3;SIK2;STK38;LONP1;PIM1;ABCD1;MKNK2;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;MTPAP;ABCG1;EIF2B2;MAP3K20;PMVK;PNPLA8;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,vinculin binding (GO:0017166),0.5510872739309784,1.122207205344565,0.3465909090909091,0.9177483722004155,1.0,6/11,12.77%,UTRN;PXN;ACTN1;CTNNA1;SYNM;RTCB
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.48828860630800824,-1.1221467247825199,0.3368869936034115,0.7741448653909024,1.0,6/12,7.16%,IGF1;IRS1;GNAS;IGF2;YWHAG;SHC1
prerank,poly-purine tract binding (GO:0070717),-0.39479676987940365,-1.1221332460406814,0.3074866310160428,0.7666680469964652,1.0,5/27,8.34%,RBMS3;ATXN1;DAZAP1;RBMS1;TIA1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.49290312861640406,1.1219318035129313,0.33613445378151263,0.9125602731577829,1.0,3/21,8.30%,POLK;PRIMPOL;POLA1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5486900816919321,1.1197538662261457,0.3576923076923077,0.9132869520835105,1.0,5/12,18.35%,PIK3C2A;PIK3R6;PIK3CG;IPMK;PIK3C2B
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5369867377494824,1.1192083953404974,0.3493761140819964,0.9091454523778264,1.0,3/12,9.15%,CDK6;CCNK;BRD4
prerank,phospholipase activator activity (GO:0016004),-0.5076633450403499,-1.1168294096784421,0.32166301969365424,0.7743796044978674,1.0,3/10,10.18%,ARHGAP6;SRC;STX4
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4396819751084565,1.1166336336202791,0.31726283048211507,0.9112677405715965,1.0,5/38,4.21%,SHANK3;NCK1;CARD10;SH2B2;SORBS1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3433735599375093,1.116572995781591,0.2440677966101695,0.9056197257580383,1.0,75/269,19.83%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;PRKAR2B;CASP8;TRAF1;NKD2;TMBIM6;RALB;DTX3L;SMAD7;HERC2;PRR5L;CD40;TRIB3;DNAJA1;ATXN3;SNCAIP;ARRB1;JAK1;UBE2G1;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC4R;MC1R;RB1;CUL1;RIPK1;GABARAPL1;RELA;PA2G4;HSP90AB1;ASB4;TRIB1;TXNIP;NDUFS2;UBE2K;TRAF6;APC;MID1;UBXN1;BAG4;CHEK2;RPL11;KDM4A;NEDD8;CUL3;YOD1;BAG1;STAT1;USP7;PARP9;RNF40;PRKACB;STAM;CUL2;USP25;BCL10;TSG101;SMAD2;GPI;NLK
prerank,receptor ligand activity (GO:0048018),-0.2737417095189493,-1.115834592052736,0.17117117117117117,0.769558522129286,1.0,44/245,14.20%,BMP6;IGF1;IL34;EPHA7;SEMA3D;PTN;EDA;NBL1;WNT4;BMP5;FGF1;BMP7;IL18;DPP4;SEMA5A;WNT6;BMP4;GREM2;FGF2;WNT9A;IL16;TNFRSF11B;IGF2;NGF;JAG1;SEMA3B;NRG3;OSGIN2;SEMA3A;VEGFB;VEGFA;INHBA;TGFB3;TGFB2;WNT16;FGF7;TAFA2;SEMA6C;GDF11;GDF1;SEMA4B;HBEGF;SEMA3G;IL17D
prerank,calcium channel inhibitor activity (GO:0019855),0.5411333351398333,1.1157568788443557,0.36414048059149723,0.9023916576381366,1.0,3/11,16.25%,FKBP1A;MCUB;CALM1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.43373234034440045,-1.1151349934088142,0.3181818181818182,0.76430531067329,1.0,3/19,7.20%,PRKN;SELENOS;AMFR
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.39402626006551156,1.1127261295673196,0.3011204481792717,0.906120061708877,1.0,13/73,13.37%,CALCRL;CYSLTR1;NPR1;NLRP6;CX3CR1;HCRTR1;MCHR1;INPP5K;APLNR;MC4R;MC1R;NPFFR1;LTB4R
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.48806350320619835,-1.1127259476586595,0.34591194968553457,0.7640779408087609,1.0,3/12,7.16%,IRS1;GAB2;SHC1
prerank,glucuronosyltransferase activity (GO:0015020),0.4875355355672563,1.1122640949664742,0.3544973544973545,0.9018652546112951,1.0,1/19,0.47%,CSGALNACT1
prerank,solute:proton symporter activity (GO:0015295),0.5103806066739054,1.1099184705492342,0.34991423670668953,0.9034658865659158,1.0,4/16,9.80%,SLC39A8;SLC2A9;SLC15A2;SLC15A1
prerank,RNA polymerase binding (GO:0070063),0.49284671652388967,1.109495003772839,0.35575221238938054,0.8992746334564766,1.0,6/18,16.50%,STOM;PKN2;NEDD4;ZFP36;PHRF1;ANP32B
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5127129953316482,1.1069805435549478,0.37544483985765126,0.8954579673955491,1.0,4/16,10.57%,ANO2;TTYH2;NMUR2;ANO6
prerank,intracellular chloride channel activity (GO:0061778),0.5127129953316482,1.1069805435549478,0.37544483985765126,0.8954579673955491,1.0,4/16,10.57%,ANO2;TTYH2;NMUR2;ANO6
prerank,histone deacetylase binding (GO:0042826),0.3839188693439972,1.1057010149394728,0.3078913324708926,0.8936763353934327,1.0,18/88,14.67%,LEF1;HDAC9;MEF2C;TAL1;PKN2;PKN1;MAPK8;HOXA10;PHF6;SP2;TFAP4;MIER1;RELA;HSP90AB1;MEF2A;MEF2D;TRAF6;KAT2B
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.41110765382289305,-1.1034108681555337,0.33665835411471323,0.7835509025892895,1.0,9/21,33.78%,P2RX4;GLRB;GRIK2;CHRNA7;CHRNB2;P2RX5;P2RX7;P2RX3;P2RX6
prerank,phosphatidylglycerol binding (GO:1901611),0.5175485743694621,1.10321480556324,0.35815602836879434,0.8956118397711339,1.0,6/13,23.71%,PLTP;PITPNC1;PITPNA;OPA1;UQCC3;STOML2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.49689988722033174,1.1017653725629943,0.35060449050086356,0.8947012727132793,1.0,8/16,20.07%,MTM1;MTMR6;SYNJ1;INPP5F;MTMR12;MTMR9;MTMR2;SACM1L
prerank,phospholipase A2 activity (GO:0004623),0.45650075540754065,1.100567050322485,0.36391912908242613,0.8927885404467095,1.0,3/26,8.49%,PLA2G4A;PLA2G2D;PLAAT3
prerank,secondary active transmembrane transporter activity (GO:0015291),0.40721586723039105,1.0969245880922036,0.3237822349570201,0.8987764991835769,1.0,10/51,10.90%,SLCO2B1;SLCO2A1;SLC25A16;SLC16A2;SLC35E4;CLCN3;ANKH;SLC25A30;SLC35D2;SLCO1B1
prerank,phospholipase binding (GO:0043274),-0.46687353820740685,-1.0963058709405276,0.35600907029478457,0.7967656904212216,1.0,2/13,1.21%,ARHGAP6;PRKN
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.44508900449577987,1.0937959272290176,0.34281200631911535,0.9031056695363439,1.0,12/28,23.27%,EDC3;DROSHA;RNASEH2A;NUDT16;DICER1;RPP30;RPP25;ENDOV;PRORP;MRPL44;RNASEH1;DBR1
prerank,rRNA binding (GO:0019843),0.4207473455598009,1.092667107570665,0.3470031545741325,0.9011477185940359,1.0,16/42,21.25%,RPS14;CAVIN1;RRS1;ANG;RPL23;MRPS18A;NOP53;FASTKD2;RPS13;EMG1;RPL11;PTCD3;MRPL11;RPS3;SBDS;RCC1L
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5317718049012703,1.0914733578328801,0.3685185185185185,0.8993650019693862,1.0,3/12,1.39%,BMPR2;ENG;ACVRL1
prerank,DNA polymerase activity (GO:0034061),0.4727774566109891,1.0893252645427145,0.3685950413223141,0.9007980950606331,1.0,3/22,8.30%,POLK;PRIMPOL;POLA1
prerank,tau-protein kinase activity (GO:0050321),0.46973780129804654,1.0875237106153082,0.3771626297577855,0.9007796550557635,1.0,5/20,6.68%,FYN;TAOK2;MARK3;SIK3;DYRK1A
prerank,ephrin receptor activity (GO:0005003),-0.41348811513255457,-1.0872570475270924,0.3616504854368932,0.80792191959311,1.0,5/17,10.27%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.41348811513255457,-1.0872570475270924,0.3616504854368932,0.80792191959311,1.0,5/17,10.27%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5175619890945371,1.0852954699264523,0.3844765342960289,0.9023720776282826,1.0,1/12,1.09%,TENT4A
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4177700040056865,1.0849340324778938,0.3629518072289157,0.8982212172602223,1.0,6/42,4.23%,ESAM;CD200;BSG;ROBO4;TMOD3;PDLIM1
prerank,double-stranded RNA binding (GO:0003725),0.3853832882934183,1.084456485589808,0.33242506811989103,0.8944589900056074,1.0,16/70,13.89%,LRRFIP1;ADARB1;MSN;SLC3A2;ACTN1;MBNL1;DROSHA;DICER1;RFTN1;RC3H1;ADAR;OASL;HSP90AB1;IFIH1;FMR1;DHX15
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.34763407266440255,1.0833375856946905,0.3277310924369748,0.8925828068260532,1.0,22/173,10.23%,ELK3;DACH1;PPARD;ZBTB16;ETV6;LRRFIP1;FOXP1;SOX13;HHEX;NR3C1;KLF8;TGIF1;ZFP57;ETS2;TCF3;NFKB1;CREM;FOXK1;BACH1;SP2;SKIL;KLF12
prerank,NADP binding (GO:0050661),0.4336446359481373,1.082425327216136,0.382262996941896,0.8904635742583686,1.0,3/32,4.11%,NOS3;LBR;CAT
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4443508782093659,1.082042114022556,0.3611111111111111,0.8865958895758044,1.0,9/28,19.21%,DAB2IP;TRAF1;BABAM2;RIPK1;BID;TRAF6;CASP8AP2;STAT1;MADD
prerank,voltage-gated sodium channel activity (GO:0005248),-0.39970973826693157,-1.078821694635859,0.3168831168831169,0.8254438320500748,1.0,11/22,29.16%,SCN7A;CACNA1G;SCN2B;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;HCN4
prerank,SUMO binding (GO:0032183),0.5030501936929233,1.0759885350899956,0.39823008849557523,0.8996445142141428,1.0,7/13,21.88%,HERC2;RNF4;SERBP1;CASP8AP2;USP25;SIMC1;RNF111
prerank,nuclear receptor coactivator activity (GO:0030374),0.40453341373769386,1.0758329959616864,0.3627167630057804,0.8949726775956285,1.0,11/52,11.32%,TACC1;CNOT6;ACTN4;ACTN1;PKN1;NCOA1;SS18;RBM14;RNF4;ZMIZ1;ENY2
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.4039824904223435,-1.0748991452814278,0.36528497409326427,0.8288806459250515,1.0,12/21,17.11%,AKAP7;AKAP6;ARFGEF2;PRKACA;EZR;AKAP8L;RYR2;WASF3;WASF1;ACBD3;PJA2;PRRC1
prerank,triglyceride lipase activity (GO:0004806),0.4763201821526293,1.0737803111676496,0.400990099009901,0.8960594633829605,1.0,4/20,18.94%,LIPE;LPL;PNPLA2;CEL
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.48455477539891256,-1.0729770140778387,0.38969072164948454,0.8271633912233083,1.0,4/10,21.59%,NOX4;CYBB;NOX1;NCF2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4050770073792466,-1.071987616559778,0.36893203883495146,0.8227321004096634,1.0,6/20,16.76%,MOGAT3;LPGAT1;AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,lipase activator activity (GO:0060229),-0.4897509091041525,-1.069959871781654,0.37901498929336186,0.8214624754315358,1.0,1/10,0.11%,ARHGAP6
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4549994722245759,1.0690273928230283,0.3843594009983361,0.9053579738202227,1.0,4/23,3.85%,PLCB4;PLCG1;PLCB1;PLCG2
prerank,sulfotransferase activity (GO:0008146),-0.3642121812853861,-1.06778991170661,0.36134453781512604,0.8208177157382275,1.0,7/33,10.63%,UST;HS3ST3A1;CHST15;TPST1;HS2ST1;CHST3;HS6ST1
prerank,phospholipase C activity (GO:0004629),-0.38773575525337384,-1.0664716634150684,0.337696335078534,0.8175182865517445,1.0,7/25,8.12%,PLCL1;PLCE1;EDNRA;PLCD3;PLCB3;PLCD1;BDKRB2
prerank,deubiquitinase activity (GO:0101005),0.37260165962892455,1.0653398159139225,0.3721244925575101,0.9108407175111946,1.0,11/88,10.53%,USP53;MINDY1;USP3;MINDY2;EIF3H;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4227830784851776,1.0596906357347722,0.41055718475073316,0.9221374218224528,1.0,4/34,2.10%,ARAP3;PARD3;HIP1R;IQGAP1
prerank,cAMP response element binding (GO:0035497),-0.48710309678359986,-1.0590531972072772,0.40825688073394495,0.8324124066066907,1.0,4/10,20.04%,CREB5;E4F1;CREB3L1;NR4A3
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.33136684998654087,-1.0574424153621218,0.34890965732087226,0.8300794881737107,1.0,11/49,14.87%,ATP1A2;MPPED2;PXYLP1;DUSP11;EPHX2;LHPP;DUSP10;PTPN22;SBF1;PPP1CB;ACP6
prerank,cysteine-type endopeptidase activity (GO:0004197),0.37216700407333847,1.05680297303792,0.3743169398907104,0.9255283031819628,1.0,13/78,12.85%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CTSK;CTSO;MALT1;CASP1;PIGK;LGMN;CAPN5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4879858821582786,1.0566660772404395,0.400679117147708,0.9208840616411318,1.0,1/16,1.45%,PIR
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.40673303113405296,1.0504681796103186,0.41140215716486905,0.9336913335893329,1.0,9/37,17.58%,GARS1;FARS2;IARS1;TARS3;LARS1;WARS1;RARS1;KARS1;WARS2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5119522523710264,1.05018411518981,0.42018348623853213,0.9296829880573991,1.0,1/11,2.28%,PPP1R2
prerank,protein phosphatase activator activity (GO:0072542),0.4824806462812465,1.0496458947182237,0.4132841328413284,0.926206736472264,1.0,3/13,8.36%,PPP2R5A;PPP2R5E;PPP2R5B
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4867189200538049,1.0493226147556158,0.41061946902654867,0.9223375906864829,1.0,5/13,18.05%,SH3BP4;CCDC88A;GDI2;EIF5;ARHGDIA
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.4213790933814615,1.0460678983938216,0.4211309523809524,0.9266368963070328,1.0,13/33,22.17%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;DCP2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3767114560123865,-1.0459347555802208,0.39941690962099125,0.8562797419718707,1.0,3/27,3.59%,LRP1;HSPG2;SYT1
prerank,myosin II binding (GO:0045159),0.5220887630597856,1.0448586815389995,0.45251396648044695,0.9253040579542832,1.0,3/10,8.81%,SHROOM4;SHROOM1;LLGL1
prerank,gamma-tubulin binding (GO:0043015),0.4506837422282572,1.043935258456705,0.4236111111111111,0.9233147222757252,1.0,11/22,26.54%,DIXDC1;RAB11FIP5;ARHGEF7;RAD51D;PAK1;CDK5RAP2;GIT1;RACGAP1;TUBGCP2;CENPJ;OFD1
prerank,steroid hydroxylase activity (GO:0008395),-0.43435498264582156,-1.043618272952302,0.38613861386138615,0.8560866773879824,1.0,3/16,4.73%,CYP7B1;CYP27A1;CYP1B1
prerank,heme binding (GO:0020037),0.379966948958272,1.042803369099181,0.41509433962264153,0.921802433665709,1.0,6/65,5.93%,NOS3;PTGS2;PXDN;CYP26A1;CAT;CYCS
prerank,NF-kappaB binding (GO:0051059),0.4437501154925439,1.042169198851629,0.4213197969543147,0.9187746538076715,1.0,6/24,14.04%,NFKBIA;TAF4B;PSMA6;RELA;RNF25;NPM1
prerank,calcium activated cation channel activity (GO:0005227),-0.408114207801278,-1.0418699841266905,0.40875912408759124,0.85433126219591,1.0,5/17,14.23%,KCNMA1;ANO1;KCNMB2;TMEM63A;KCNN2
prerank,CoA-ligase activity (GO:0016405),-0.43613358872968455,-1.0403171410490253,0.39908256880733944,0.8520756982576392,1.0,4/14,20.85%,ACSL1;AACS;ACSS2;ACSBG1
prerank,diacylglycerol kinase activity (GO:0004143),0.5068909594208674,1.0394932537036448,0.4312977099236641,0.9217842181897002,1.0,3/11,11.25%,DGKZ;DGKH;DGKE
prerank,DNA replication origin binding (GO:0003688),0.4346064561999986,1.0388368300556379,0.4132231404958678,0.9191055160119408,1.0,6/23,16.13%,MCM10;POLA1;MCM9;GRWD1;ORC5;ORC3
prerank,voltage-gated ion channel activity (GO:0005244),0.4858012412721,1.0387266153136916,0.4112478031634446,0.9146897396966664,1.0,4/14,10.57%,CACNA1E;PKD2;VDAC3;ANO6
prerank,cysteine-type peptidase activity (GO:0008234),0.3700964198704956,1.0381133503494253,0.41838134430727025,0.9118385740756425,1.0,10/73,8.27%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CTSK;CTSO;MALT1;CASP1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3718554160443056,1.0380099320186795,0.4043419267299864,0.907558023551143,1.0,9/72,4.84%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.44233002317299397,1.036402768211211,0.4206219312602291,0.9074442495442436,1.0,8/22,21.31%,PPM1F;DUSP23;DUSP16;DUSP7;DUSP2;DUSP19;MTMR2;DUSP18
prerank,mRNA 5'-UTR binding (GO:0048027),0.4377610369225319,1.0355181950842212,0.41367521367521365,0.9052723286644064,1.0,10/24,26.35%,IGF2BP3;RPS14;RPS7;FMR1;RPS13;DHX36;RPL26;MRPS11;RPL41;SYNCRIP
prerank,5'-3' exonuclease activity (GO:0008409),0.4828712931221624,1.0355050102935748,0.4305555555555556,0.9008520768477455,1.0,5/14,18.04%,FAN1;DCP2;TRIR;XRN2;DCLRE1C
prerank,calcium-activated potassium channel activity (GO:0015269),-0.4526533524069102,-1.0340332296403454,0.43612334801762115,0.8627523846452113,1.0,5/11,20.11%,KCNMA1;KCNMB2;KCNN2;KCNN3;KCNU1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3636216417875334,1.0264053409212746,0.4155844155844156,0.920831975135933,1.0,8/70,8.78%,CSGALNACT1;LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3360761645909005,-1.0247418444717986,0.40476190476190477,0.8823728897013116,1.0,9/35,11.39%,PLCL1;MPPED2;PLCE1;ENPP1;PLCB3;ENPP3;TDP2;SMPD3;SMPD4
prerank,transition metal ion binding (GO:0046914),0.30708566363420947,1.0235055298055475,0.4394904458598726,0.9243304481024491,1.0,59/397,13.79%,MYRIP;SHANK3;NOS3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;KDM3A;TES;LCN2;TET3;ENPP2;ASAH2;MYCBP2;PAM;ABO;EEA1;ADAMDEC1;RNF7;SIRT5;ERAP1;KDM4C;PRIMPOL;ZNF2;TRIM24;PGGT1B;ANG;NUDT16;PTPN1;AFM;SIAH1;ATP7B;CYP2R1;RC3H1;RPS27;ABL2;ZMYND11;PITRM1;RNF112;PIM1;PRDM2;ADH1A;MGAT5;ETHE1;SIRT6;TET2;SORD;TMEM163;AOC1;IFIH1;ACR;MTPAP;RPS29;SOD2
prerank,neurexin family protein binding (GO:0042043),-0.45825470145736846,-1.0225581405668411,0.453781512605042,0.8815374328693597,1.0,5/10,10.58%,NLGN2;NLGN1;SYTL2;SYTL5;NLGN3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4507935385222988,-1.020441712547396,0.4469026548672566,0.8804157376890267,1.0,8/11,36.70%,NDUFAF7;CARM1;PRMT9;PRMT8;PRMT2;PRMT7;PRMT6;PRMT1
prerank,amino acid binding (GO:0016597),0.41248117147823427,1.0201923142609726,0.42857142857142855,0.9286403507788735,1.0,2/31,4.82%,NOS3;PADI4
prerank,anion channel activity (GO:0005253),0.36733490630693366,1.0189381172671943,0.4297872340425532,0.9276636360492885,1.0,8/61,10.73%,LRRC8C;ANO2;LRRC8B;BEST1;CLCN3;VDAC3;ANO6;GABRD
prerank,iron ion binding (GO:0005506),-0.3168669668756391,-1.0174062822197034,0.4353312302839117,0.8820935943563246,1.0,13/48,20.29%,AGMO;AOX1;KDM7A;TET1;EGLN3;FDX1;SCD;FTO;SNCA;ACO2;NFU1;ABCE1;SCD5
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5026908620418659,1.016893427417027,0.46034816247582205,0.9287583809921318,1.0,2/11,7.06%,KCNQ1;KCNE2
prerank,metalloexopeptidase activity (GO:0008235),-0.32336656517271356,-1.0166983484981733,0.42394822006472493,0.877394338891043,1.0,8/51,8.95%,AEBP1;CPQ;MMP14;MMP16;NPEPPS;ENPEP;CPXM2;CPXM1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5092213047060569,1.0163905697805542,0.44573643410852715,0.9257668151824114,1.0,4/10,17.35%,ATXN3;OTUD4;YOD1;DESI2
prerank,MHC class II protein complex binding (GO:0023026),-0.4405068244284661,-1.0151009874099637,0.4541577825159915,0.875344902604418,1.0,3/11,11.16%,ATP1B1;HSP90AA1;CD81
prerank,Notch binding (GO:0005112),-0.3822795762639863,-1.0148820541944785,0.4557291666666667,0.8693703220651651,1.0,5/22,7.80%,SNED1;AAK1;JAG1;CCN3;DTX1
prerank,I-SMAD binding (GO:0070411),0.48444628068808343,1.0148069020369652,0.4727272727272727,0.9256612461655177,1.0,4/13,10.28%,SMAD1;SMURF1;SMAD7;SMAD5
prerank,phosphatase inhibitor activity (GO:0019212),0.4452957642997245,1.0143794754798052,0.4659498207885305,0.9223259735555748,1.0,5/20,15.04%,PPP1R2;PPP1R9B;LMTK2;MGAT5;STYX
prerank,histone acetyltransferase binding (GO:0035035),0.4419210897307866,1.0122812469581064,0.44976076555023925,0.9237209694915549,1.0,3/21,5.40%,EPAS1;HIF1A;TRIM68
prerank,cation transmembrane transporter activity (GO:0008324),-0.3200694886459331,-1.0097425512112082,0.45288753799392095,0.8775465223741791,1.0,5/48,3.53%,SLC7A2;SLC41A1;SLC1A5;SLC6A9;SFXN2
prerank,protein heterodimerization activity (GO:0046982),0.32319255565683086,1.0095870205768953,0.460166468489893,0.9264671117600702,1.0,23/178,8.26%,EPAS1;ZHX3;RALGAPA2;MEF2C;AHR;PDGFB;HIP1;FZD4;HIF1A;RALGAPA1;KCNB1;ADRB1;IKBKB;SDCBP;XBP1;TCF4;ATP1A1;BOK;AURKA;ITGA3;TCF3;MICU2;NEUROD1
prerank,thyroid hormone receptor binding (GO:0046966),0.41221604025666103,1.0093387263470281,0.4605873261205564,0.922793509948923,1.0,8/28,22.79%,TACC1;JMJD1C;OASL;GTF2H1;TAF7;GAS2L1;MED12;MED17
prerank,pyrophosphatase activity (GO:0016462),0.37621485487064477,1.0083815523560136,0.46449704142011833,0.9211027261548704,1.0,14/50,19.50%,ENTPD1;PLPP1;BNIP2;NUDT16;RNGTT;PRUNE1;DCP2;NUDT15;NUDT14;PLPP5;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4766953443793499,1.008157932314158,0.46098003629764067,0.9173912234793095,1.0,2/13,10.53%,ECI1;ECH1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.44975624504903505,-1.0079839705355742,0.43736263736263736,0.8756170678210345,1.0,3/11,2.92%,AKAP13;SH3RF1;KSR1
prerank,kinase activity (GO:0016301),0.3368844885155102,1.007750840931823,0.45512010113780027,0.9142780001000184,1.0,26/109,18.35%,PRKD1;DGKZ;LYN;PRKD3;PIK3C2A;PKN2;DGKH;ITPKB;TRIB3;PIK3CG;CERKL;PANK2;NMRK1;EPHA4;GK5;DGKE;IDNK;CHKA;PMVK;RFK;PANK3;PAPSS1;DOLK;IPMK;CSNK2A1;PIK3C2B
prerank,calcium ion binding (GO:0005509),-0.24378266103059007,-1.0054753897617077,0.463768115942029,0.8757548863326295,1.0,52/323,11.30%,LRP1;FBN1;GSN;CDH11;FBLN1;ENPP1;ADGRV1;SPARC;CLEC3B;KCNIP4;ANXA5;SLC8A1;CDH13;THBS1;GJB2;SYT1;ASPH;SMOC2;C2CD5;CDH1;SCUBE1;S100A6;AMY1B;AMY1A;AMY1C;ANXA1;PCLO;NRXN1;RASGRP2;RCN3;THBS3;STIM1;SYT9;PLSCR2;SYT12;SYT11;ANXA2;ASPN;S100B;ANXA6;PITPNM3;ATP2A2;RCN1;ENPP3;ANXA3;RYR2;SLC25A12;TKT;S100A10;SLIT2;ANXA4;MICU1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3578762684966169,-1.0045581304967384,0.45671641791044776,0.8717839791985037,1.0,7/27,7.88%,SLC26A7;SLC22A8;SLC26A2;ANO1;SLC22A6;SLC39A14;SLC5A5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.44092537659341435,-1.0028323792462883,0.45490981963927857,0.8700124248916714,1.0,4/11,18.54%,AMFR;UBE4B;UBE4A;UBR5
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3407729748667888,-1.002240803469235,0.4525,0.8653663087029576,1.0,10/33,19.53%,AR;RECQL5;CTR9;PAF1;ERCC5;DRAP1;WDR43;HNRNPU;UVSSA;ELP4
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4229951670387855,1.0000852892231138,0.4630541871921182,0.9298912258329645,1.0,4/23,7.55%,HIP1;HIP1R;PLEKHA5;SNX3
prerank,chemokine binding (GO:0019956),-0.3427466833455529,-0.9991912506440171,0.45287958115183247,0.8673073328851459,1.0,4/30,5.58%,PDPN;CCR9;FGF2;ITGAV
prerank,serine-type endopeptidase activity (GO:0004252),-0.28589712950041096,-0.9964209243677252,0.5,0.8686229435550878,1.0,9/80,9.22%,F3;RHBDL3;DPP4;PCSK5;FAP;KLK2;PLAT;RHBDF1;MMP2
prerank,retinoic acid binding (GO:0001972),0.48112534995763395,0.9948641164821063,0.48417132216014896,0.9394454864526632,1.0,2/12,6.56%,CYP26A1;CYP26C1
prerank,actinin binding (GO:0042805),-0.3716385454256496,-0.9943031939605549,0.484375,0.8680609065584275,1.0,3/21,3.02%,CACNA1C;CACNA1D;DAG1
prerank,voltage-gated potassium channel activity (GO:0005249),-0.28805506555456084,-0.9942287979785844,0.4642857142857143,0.8622104866500282,1.0,23/80,18.86%,KCNK2;KCNB2;KCNMA1;KCNQ3;KCND2;KCND3;KCNC2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNQ5;KCNA6;KCNJ10;KCNT1;KCNN2;KCNJ8;KCNJ15;LRRC38;KCNJ6;KCNE4;KCNN3;KCND1
prerank,fibroblast growth factor binding (GO:0017134),-0.37098054735953456,-0.9938085320075082,0.47619047619047616,0.8572244351228453,1.0,4/21,10.71%,FGFR2;THBS1;ITGAV;FGFR4
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.45555204485487627,0.9918924272666588,0.4626334519572954,0.9428469910371319,1.0,6/14,19.93%,MTM1;MTMR6;SYNJ1;MTMR12;MTMR9;MTMR2
prerank,syntaxin-1 binding (GO:0017075),0.4291948703662283,0.991471188688255,0.47704918032786886,0.9395848721884008,1.0,3/22,4.38%,UNC13B;DAPK1;SYPL1
prerank,kinesin binding (GO:0019894),-0.34893600531155067,-0.9908742398465703,0.48214285714285715,0.8593156262117099,1.0,16/27,30.98%,ARHGEF10;IFT88;PLEKHM2;RAB29;KIF1B;TTBK2;KIFAP3;SNCA;PRC1;KLC2;KIF18B;TOR1B;TOR1A;CROCC;NEFH;FAM83D
prerank,thioesterase binding (GO:0031996),0.48415219951298993,0.9903375284758358,0.4766355140186916,0.9382124470348899,1.0,3/11,14.18%,TRAF1;RAC1;TRAF6
prerank,cell adhesion mediator activity (GO:0098631),0.4221543245774446,0.9902836777665576,0.46808510638297873,0.9341524808632726,1.0,5/24,9.24%,ESAM;BSG;ROBO4;BCAM;DSCAM
prerank,PDZ domain binding (GO:0030165),0.35373429807915263,0.9891627978768114,0.459802538787024,0.9328343318105353,1.0,11/61,6.54%,CADM1;F11R;USHBP1;FZD4;SNTG2;DOCK4;ADRB1;CLCN3;ATP2B4;RAPGEF2;TMEM88
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4149418838145898,0.9866485675977196,0.48360655737704916,0.9351015982965185,1.0,4/26,8.78%,CSGALNACT1;B3GNT3;B3GNT4;B3GNT6
prerank,sodium channel activity (GO:0005272),-0.3232516551269329,-0.9815527498842617,0.49375,0.8785303044483961,1.0,15/37,29.16%,SCN7A;CACNA1G;GRIK4;GRIK2;GRIK5;GRIK1;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;SCNN1A;HCN4
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3026049746459743,-0.9810719037836207,0.47194719471947194,0.8737489841554813,1.0,7/53,6.15%,MICAL3;MICAL2;DDO;AOX1;DPYD;NOX4;PRODH
prerank,cAMP binding (GO:0030552),0.4800972518714406,0.9789083290441362,0.48148148148148145,0.9505675792751577,1.0,3/11,6.11%,PDE2A;PDE4D;RAPGEF2
prerank,lipid phosphatase activity (GO:0042577),0.4648732016935131,0.9764059494850876,0.4898336414048059,0.9528814193749193,1.0,3/14,6.60%,PLPP1;SGPP2;INPP5K
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4474901006825691,-0.9763201316857463,0.5052854122621564,0.8796490756054264,1.0,5/10,24.91%,NAA40;BRCA2;KAT8;NAA60;USP22
prerank,transforming growth factor beta receptor binding (GO:0005160),0.44409886775811885,0.975606456944823,0.5094017094017094,0.9508408171201497,1.0,5/18,7.32%,ENG;FKBP1A;SMAD7;USP15;TGFB1
prerank,copper ion binding (GO:0005507),-0.3133281667439591,-0.9751755550416036,0.4967948717948718,0.8766005051193109,1.0,10/42,18.32%,MOXD1;P2RX4;LOXL3;SOD3;LACC1;CCS;SNCA;GPC1;MT3;COX17
prerank,titin binding (GO:0031432),-0.4227406173044971,-0.974423158638362,0.502283105022831,0.8727132674596834,1.0,2/13,10.96%,ACTN2;TRIM63
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.41540306393030074,0.9729613930293721,0.5199335548172758,0.9534070310617374,1.0,3/25,2.00%,ARAP3;HIP1;HIP1R
prerank,hyaluronic acid binding (GO:0005540),0.4782413390928554,0.9720048803988066,0.5055555555555555,0.9516717797877787,1.0,1/10,1.12%,LAYN
prerank,nucleotidyltransferase activity (GO:0016779),0.4277217935050939,0.9667410581903015,0.521594684385382,0.960536342745994,1.0,6/19,19.05%,TENT4A;CGAS;MTPAP;PNPT1;PAPSS1;YRDC
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4008918914987794,0.966419346852413,0.5188834154351396,0.957314041114977,1.0,5/24,12.04%,DAPK1;PTK2B;MAPKAPK3;EEF2K;MKNK2
prerank,O-acyltransferase activity (GO:0008374),0.3914592672228733,0.9656661867271126,0.5145631067961165,0.9551914285969104,1.0,7/30,15.78%,PLA2G4A;LPCAT3;SOAT2;MBOAT1;MOGAT1;DGAT1;MOGAT2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.37843975319959805,0.9643584762283338,0.500823723228995,0.9542437150576148,1.0,4/34,4.49%,IQGAP1;CCNK;STK3;STK4
prerank,ADP binding (GO:0043531),0.4041147024876353,0.964285673388912,0.49836601307189543,0.950365195006804,1.0,5/25,13.76%,ERN1;MYH9;LONP1;ABCD1;ABCG1
prerank,ATPase binding (GO:0051117),0.3430261507218852,0.9637858372128302,0.5041782729805014,0.9475610791730096,1.0,15/71,9.23%,CAV1;ESR1;PPP3CA;PDE4D;NKD2;RALB;ATXN3;ATP1B3;LCK;ATP6V0A1;PKD2;PSEN1;PEX26;CHMP4A;ANK1
prerank,U6 snRNA binding (GO:0017070),0.45173932305527115,0.9613348790570191,0.5278276481149012,0.9494162679612295,1.0,9/14,26.99%,LSM8;LSM3;LSM7;PRPF4;SART3;EIF5A;LSM2;TUT1;METTL16
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3886562865740093,-0.9602963870002955,0.4930232558139535,0.9032017577872562,1.0,6/16,30.95%,SLC22A4;SLC25A42;SLC22A2;SLC22A3;SLC5A7;SLC29A4
prerank,kinase activator activity (GO:0019209),-0.3321747956873152,-0.9589699821202874,0.5118110236220472,0.9009056849900751,1.0,15/30,28.01%,GPRC5C;PRKAG2;SPDYA;STRADA;RGCC;WNK1;GPRC5B;WNT11;MT3;AGAP2;GPRC5A;TPX2;EPO;TREM2;FGF13
prerank,ubiquitin protein ligase activity (GO:0061630),0.2984139555281341,0.9585195065564409,0.5712656784492588,0.9521715733164658,1.0,51/228,16.72%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL3;NEURL1B;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;RNF215;UBE2K;TRAF6;TOPORS;MSL2;ARIH2;RNF5;UBE3D;AREL1;BIRC2;NHLRC1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3834722914718839,-0.9583763700124708,0.5195402298850574,0.8965970082243219,1.0,8/17,24.58%,DPYD;TECR;BDH2;MECR;DECR1;DHCR24;DHCR7;PECR
prerank,carboxy-lyase activity (GO:0016831),-0.34712321833267273,-0.9580446602943421,0.5377358490566038,0.8917055047429338,1.0,6/23,20.24%,ECHDC1;GGCX;ODC1;AZIN1;PCK2;DDC
prerank,lysophospholipase activity (GO:0004622),0.427443608001874,0.957909630991189,0.526829268292683,0.9496699091593251,1.0,4/20,14.60%,PLA2G4A;ENPP2;GDPD1;PNPLA6
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4707621332012647,0.9565913886004878,0.5258126195028681,0.9489181674747943,1.0,2/10,7.41%,PIK3C2A;PIK3CG
prerank,galactosyltransferase activity (GO:0008378),0.465906555216133,0.955839109609423,0.5340909090909091,0.9468389138996962,1.0,4/11,10.65%,B4GALT4;B4GALT5;B3GNT6;A4GALT
prerank,RNA binding (GO:0003723),0.27653636463680153,0.9550082356675569,0.6649949849548646,0.9450359125352303,1.0,471/1321,26.42%,NANOS3;SORBS2;NOVA2;PRPF38B;RBPMS;SPTBN1;FLNB;LRRFIP1;ADARB1;MYH9;FASN;STAT3;ANP32A;SAMHD1;MSN;DHX40;SNTB2;SLC3A2;LBR;ACTN4;DDX54;RPS15;TMSB4X;PKN2;TES;ACTN1;IGF2BP3;IMP3;RPS19;RPS14;RBM20;MBNL1;PTBP3;RPSA;MBNL2;RPS16;CAVIN1;RPL38;NANOS2;FARS2;EIF4E;N4BP1;CTNNA1;EDC3;EIF3H;UCHL5;RPL34;RPS20;RPL39;DROSHA;PPP1R10;HNRNPF;CNBP;SF3B4;RPS7;UBAP2;NXF2;MBNL3;SYNE1;RPS24;TASOR;ZNFX1;SEC63;HNRNPA0;MTREX;HNRNPK;FCF1;RBM14;NOSIP;RPL37A;GTF2E2;ZNF326;SRBD1;ASCC3;HNRNPD;WRAP53;RPF1;RPL36;TRIM25;EIF1AX;EIF1;RPS18;WDR33;SPATS2;SAMSN1;RSL24D1;DDX50;RPL15;NELFE;DYNC1LI1;RBM25;PHF6;RRS1;SUCLG1;GLRX3;ANG;PINX1;THOC2;NAP1L4;RPS8;KHNYN;NPM3;MYBBP1A;LSM8;RPL14;SUB1;YBX3;GDI2;RPL23;RPL17;DUT;NUDT16;CHD2;TBCA;NIFK;DNTTIP2;PTRH1;PTPN1;DICER1;G3BP1;PUM1;RFTN1;HELZ;HNRNPLL;SMG7;RPL9;SERBP1;RPL4;TWF2;RPL13A;RBM18;CNOT1;HELB;RPS11;RPL32;PSMA6;OTUD4;RBM3;SUMO2;FSCN1;YTHDC1;RC3H1;PPHLN1;RPL22;SPEN;RBM15;RPS27;DRG2;RPL31;RPS23;KCTD12;TFB2M;RO60;EXOSC1;CFAP65;ADAR;DDX51;DCP2;RNPS1;MRPL13;RPL13;LSM3;MRPS12;RPS12;PUM2;SRP9;LONP1;RPP30;NUP98;FAU;EIF5B;PEBP1;APEH;OASL;RPP25;NOP53;UTP4;RSRC2;HNRNPC;PA2G4;RPL6;ZFP36;RPL10;RACK1;FASTKD2;RTCB;EIF2AK4;SLTM;RNMT;HSP90AB1;TOP1;NOP16;FBLL1;BTF3;MRPL41;IFIH1;NOL10;GRWD1;FMR1;MTPAP;RPS6;CAST;POLR1G;SF3B6;DHX15;R3HDM1;NPM1;FBRSL1;QKI;SCAF11;MAP3K20;RPL29;ZC3H12C;RRP9;MRPL4;LARP4B;ADAT1;PELP1;RPS25;SRFBP1;YY1;NSRP1;RPL35A;RPS13;RPS21;SNW1;RPL27;RPL18;XRN2;AIMP1;ENDOV;MRPL23;RPL7L1;TPT1;EMG1;RPL27A;LSM14A;YBX1;YLPM1;NELFCD;MRPS5;RRP1B;KARS1;ZCCHC17;AQR;CEBPZ;RBM42;RPS10;RDX;DDX20;G3BP2;EIF5;BAG4;LUC7L2;UTP6;HNRNPUL1;MRPL37;CWC22;AGFG1;PNPT1;ZC3H4;ANXA11;VIRMA;ZFP36L1;PDCD11;TRMT6;MAK16;PRDX1;RPL11;ALYREF;XPOT;UBE2I;CDC40;CSDE1;HEATR1;LSM7;ESF1;PRPF40A;RPL8;PHF5A;EEF2;NOP14;PTCD3;ZCCHC7;MRPL11;HELZ2;PRKRIP1;METTL14;GRB2;RALY;HSPE1;DIAPH1;LARP4;TXN;RPL18A;HNRNPM;BST2;CISD2;HMGN5;MRPL54;KDM1A;PPP1CC;STRAP;NUDT1;MRPS9;DHX34;DHX36;YRDC;HNRNPAB;CPNE3;SRSF10;FUS;EIF2AK2;BCCIP;MEX3C;ZNF638;HDGF;NOM1;THOC5;ERH;RPL21;LSM1;MRPL43;MRPS26;SART1;RPL3;CCDC47;DAZL;GNL2;MRPL12;SART3;MRPL44;RPS3;DEK;UBE2L3;PURA;PPIB;SBDS;ELAVL1;PEF1;ZCCHC3;RPS28;DDX47;NOL4;SETX;RPN1;DENR;RCC1L;TAF15;PRKRA;KPNB1;URB1;RPL7;RNASEH1;SF3A2;CPSF6;JMJD6;TOE1;RIDA;CCDC9B;LUC7L;TCOF1;ZC3H14;RTF1;MRPS30;THUMPD1;GCN1;NOCT;CDK11B;TRNAU1AP;NOA1;PRPF3;RPL26;EIF4ENIF1;PURB;HMGB1;RTRAF;LACTB2;MRPL1;JUN;RBM7;NGDN;PIN4;NOL6;TRA2B;PPIA;DBR1;SRP19;RARS2;SNRPD3;EIF4E2;YWHAE;SND1;FUBP1;RPUSD2;NSUN6;MAP4;PUS7;FKBP4;SRSF4;ALKBH8;RRP12;DCP1B;SMG6;DNAJC2;RBM33;PPIG;PCDHGA9;NUP42;MRPL39;EIF5A;TENT4B;DDX28;PSPC1;MKRN2;LAS1L;LYAR;EIF3G;EIF4H;ZFR;CPSF2;SYF2;MRPL14;MRPL32;SECISBP2L;MRPS11;MRPL9;LSM2;HNRNPA3;PNO1;AARS2;MTIF2;PCF11;SNUPN;DIDO1;ISG20L2;RBMX;DDX6;SNRNP200;SUMO1;DAP3;NOLC1;ADK;PCID2;MRPL15;RCC2;LARP1B;CPSF3;PUF60;PABPC1L;RPS17;PABPC4L;MRPL42;GSPT2;PRPF40B;ISY1;GFM1;RPL28;WDR46;TRMT10C;UBE2N;DDX60;TCF20;RPL41;NCOA5;RP9;SYNCRIP;RPS2;EDF1;GTPBP4;ACAA2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3437084802345546,0.954087589013479,0.5315068493150685,0.9433910852282285,1.0,16/69,15.78%,PLA2G4A;CERS4;LPCAT3;GLYAT;SOAT2;ZDHHC18;PLAAT3;KAT6B;ZDHHC9;HHAT;MOGAT1;KAT2B;DGAT1;KAT6A;NAA16;MOGAT2
prerank,poly(A) binding (GO:0008143),-0.3561879349453809,-0.9535821898272995,0.5236907730673317,0.8974892110603627,1.0,5/21,15.49%,RBMS3;RBMS1;TIA1;HNRNPU;ELAVL4
prerank,endopeptidase regulator activity (GO:0061135),-0.31315216221181974,-0.9535206876437119,0.5284090909090909,0.8918485534528262,1.0,7/40,11.31%,TFPI;ITIH2;RENBP;RECK;SERPIND1;APH1B;CST3
prerank,alpha-tubulin binding (GO:0043014),0.3865946773923589,0.9494758945699515,0.5461658841940532,0.9508547698445442,1.0,5/31,10.09%,FYN;DIP2B;TTLL7;TRPV4;ARL8B
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3582575534161493,0.9489886563731406,0.5315315315315315,0.9481760351335178,1.0,4/49,3.38%,MCTP1;PLA2G4A;CPNE8;ESYT2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4385093442189537,-0.9484593640997063,0.5199115044247787,0.8987721339020293,1.0,3/10,12.48%,KDM7A;KDM2A;KDM8
prerank,gated channel activity (GO:0022836),0.44520714854181404,0.9481830662010053,0.5339130434782609,0.9462351022032504,1.0,1/14,1.04%,PIEZO1
prerank,adenylyltransferase activity (GO:0070566),0.4153959607700221,0.9474720698418072,0.5129087779690189,0.9440560613298159,1.0,5/21,15.49%,TENT4A;GPHN;OASL;MTPAP;KARS1
prerank,telomerase RNA binding (GO:0070034),0.4048507565518833,0.9473297943755995,0.533003300330033,0.9405463239511102,1.0,9/22,24.33%,WRAP53;PINX1;SMG7;DCP2;HNRNPC;DHX36;SNRPD3;SMG6;TENT4B
prerank,syntaxin binding (GO:0019905),0.3400455801002143,0.9472662777306295,0.5518207282913166,0.9369808488166472,1.0,11/61,12.81%,UNC13B;DAPK1;RAB11A;SYPL1;STX6;STX7;CACNA1A;SNAP23;VAMP8;STX8;STXBP3
prerank,protein kinase regulator activity (GO:0019887),-0.2597146616535988,-0.9472544100863791,0.5916666666666667,0.8960205283734622,1.0,30/95,19.53%,PARVA;TAOK3;GPRC5C;CCND2;DNAJC3;PRKAG2;KIDINS220;SPDYA;CCNL2;STRADA;PRKAR1B;RGCC;WNK1;PRKAG3;CCNL1;GPRC5B;PRKAR1A;CDKN1A;CCNT2;CCNG2;SMCR8;WNT11;SNCA;CDKN1C;MT3;PRKAG1;DUS2;CSNK2B;CCNF;ELP4
prerank,C-C chemokine binding (GO:0019957),0.3991670109636134,0.9459843215874612,0.5366269165247018,0.9361069221888709,1.0,6/22,20.77%,ACKR1;CX3CR1;CXCR4;ZFP36;CCR1;CXCR6
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4319863773219238,0.9450940531043063,0.5276381909547738,0.9343478912794908,1.0,3/15,7.55%,PLA2G4A;PLEKHA5;SNX3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4449037252390846,0.9439618716925369,0.5315315315315315,0.933218866935676,1.0,2/13,2.68%,SLC7A7;SLC38A5
prerank,hydro-lyase activity (GO:0016836),-0.31108455550368785,-0.9427551346725613,0.5896656534954408,0.9019686759169732,1.0,13/41,16.39%,GMDS;HACD3;ECHDC1;ENO2;CA4;HACD1;ECHDC3;ECHDC2;L3HYPDH;CBS;NAXD;ENO3;ACO2
prerank,exoribonuclease activity (GO:0004532),0.4544991296670273,0.9417073632631542,0.5440900562851783,0.9347970828926125,1.0,3/12,13.14%,CNOT6;EXOSC1;CNOT7
prerank,Wnt-activated receptor activity (GO:0042813),0.43937970418674865,0.9405268100224395,0.5474576271186441,0.9340277926757656,1.0,4/15,4.58%,FZD6;FZD4;LRP5;TSPAN12
prerank,nuclear export signal receptor activity (GO:0005049),0.4523077796528955,0.9396116897306062,0.5400696864111498,0.9323981691499041,1.0,5/11,24.26%,XPO1;NUP214;CSE1L;EIF4ENIF1;NUP42
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3258172189568961,0.9395930228185573,0.558047493403694,0.9287909745872779,1.0,11/91,7.55%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP;PLEKHA5;SNX3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2921610381194159,0.9387119534988313,0.590702947845805,0.9271789209454596,1.0,50/232,16.72%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL3;NEURL1B;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;RNF215;TRAF6;TOPORS;MSL2;ARIH2;RNF5;UBE3D;AREL1;BIRC2;NHLRC1
prerank,sterol binding (GO:0032934),-0.2839038031113251,-0.9383619972974694,0.5914634146341463,0.9079434523156311,1.0,17/56,15.61%,SIDT1;GRAMD1B;GRAMD1C;INSIG2;APOD;RORA;OSBPL8;OSBPL5;ANXA6;SOAT1;OSBPL3;CD81;OSBPL6;VDAC1;INSIG1;SCP2;SYP
prerank,androgen receptor binding (GO:0050681),0.3963996725796527,0.9383591084704536,0.5618892508143323,0.9244877832249566,1.0,5/25,8.10%,FOXP1;KDM3A;PKN1;TRIM68;KDM4C
prerank,active ion transmembrane transporter activity (GO:0022853),0.37239087380205504,0.9379706409079911,0.537890044576523,0.9217828459458568,1.0,2/37,1.65%,SLCO2B1;SLCO2A1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3088274167892125,0.9374674203378613,0.5680981595092025,0.9193092286379055,1.0,9/134,4.92%,ABCC4;SLCO2B1;ABCG2;SLC39A8;SLCO2A1;SLC38A5;SLC3A2;SLC6A6;SLC35B3
prerank,MAP kinase activity (GO:0004707),-0.39611776386960906,-0.9353650617044652,0.5688073394495413,0.9098550794881736,1.0,2/14,7.31%,MAPK4;MAPK10
prerank,cyclic nucleotide binding (GO:0030551),0.40105676230436793,0.9333960700195866,0.5331010452961672,0.9248844072537733,1.0,4/21,6.11%,PDE2A;PDE4D;CNGB1;RAPGEF2
prerank,chemoattractant activity (GO:0042056),0.3975103039964951,0.9329620933826833,0.5601317957166392,0.9222241218553973,1.0,3/26,5.07%,PDGFB;VEGFC;VEGFD
prerank,protein phosphatase inhibitor activity (GO:0004864),0.38834139099915826,0.9323750670080586,0.5380875202593193,0.9200721827693706,1.0,3/26,4.53%,PPP1R2;PPP1R9B;LMTK2
prerank,transaminase activity (GO:0008483),-0.4213645430734626,-0.9323558977355324,0.5407725321888412,0.9114486572146265,1.0,3/11,12.73%,ABAT;GOT1;OAT
prerank,mechanosensitive ion channel activity (GO:0008381),0.456811923655852,0.9321959728208136,0.5469613259668509,0.9169941681884652,1.0,1/12,1.04%,PIEZO1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.45568471256978693,0.9318862038084704,0.5437262357414449,0.9141121271395773,1.0,2/11,12.99%,PADI4;PADI1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.38812648290527174,0.9305443344486661,0.5421133231240429,0.9137620806808062,1.0,4/29,11.52%,ACER2;CTBS;PARG;OVGP1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3444273311015587,0.9303462430113822,0.5602322206095791,0.9108764615691942,1.0,12/56,15.28%,PTPN14;PITPNM2;DOCK4;NCK1;SH2B2;GRB14;PTPN1;GAS6;CBL;RACK1;LRP4;ALKAL2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3214997847116531,0.9281103028318917,0.5660639777468707,0.9123197479469427,1.0,11/75,13.15%,ABCC4;RDH16;HADHA;CBR1;GLYR1;SPR;LDHD;ADH1A;SORD;HADH;IMPDH1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3906388731944135,-0.9278702756495121,0.5639097744360902,0.9170738012149411,1.0,2/14,3.03%,SLC26A7;SLC26A2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3270274899295519,0.9250110881348431,0.5702592087312415,0.9155280381171789,1.0,16/83,19.17%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,neuropeptide binding (GO:0042923),0.41477564089986646,0.9243351098787517,0.5474576271186441,0.9135967486766379,1.0,4/18,18.64%,MCHR1;NMUR2;MC4R;OPRL1
prerank,RNA cap binding (GO:0000339),-0.37634375773671924,-0.9228732374972217,0.5700483091787439,0.9239967933545364,1.0,3/16,10.90%,CYFIP2;EIF4A1;EIF4E3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3122186181532508,-0.9219546744017753,0.5814606741573034,0.920661723678113,1.0,9/32,16.59%,KDM7A;TET1;KDM2A;EGLN3;P4HTM;KDM8;BBOX1;FTO;PHYHD1
prerank,G protein-coupled receptor binding (GO:0001664),-0.24726768124812307,-0.9212715858438119,0.6777777777777778,0.9167988532083143,1.0,28/132,15.82%,WNT4;PRKN;GRK3;RNF43;BICD1;WNT6;TULP3;GNAO1;WNT9A;GNAS;RYK;AGTR1;LRP6;GPRASP2;GNAI1;SFRP1;CXCL12;USP33;FZD1;GPRC5B;WNT16;FZD7;S1PR2;GNA14;ARHGEF11;WNT11;PTCH2;DVL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.447524368234383,0.919016648334616,0.5626168224299065,0.9184038549037719,1.0,5/11,20.73%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,adenyl nucleotide binding (GO:0030554),0.447524368234383,0.919016648334616,0.5626168224299065,0.9184038549037719,1.0,5/11,20.73%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.38102691440815284,-0.917959008293865,0.5767441860465117,0.9191406961697118,1.0,2/15,7.48%,P2RX4;P2RY14
prerank,histone deacetylase activity (GO:0004407),0.40848749666757167,0.9175764209806996,0.5651408450704225,0.9180324824102243,1.0,1/19,0.51%,HDAC9
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3993028220686099,0.9165947951605722,0.5571177504393673,0.916788523410416,1.0,4/21,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4340264479985803,0.9155712669212084,0.5610619469026549,0.9156911231922084,1.0,5/12,18.64%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3895426854459666,0.9148194758942779,0.5542168674698795,0.9139490578538946,1.0,4/23,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4127465810904898,-0.9144303372240192,0.5920502092050209,0.92193743571407,1.0,4/10,8.09%,DPP4;FAP;NAALAD2;DPP6
prerank,ribosomal small subunit binding (GO:0043024),0.4130454617314504,0.9138628707617398,0.5577889447236181,0.912808757617612,1.0,6/17,17.60%,EIF1;UNG;PIM1;NPM1;MTIF3;PTCD3
prerank,ion gated channel activity (GO:0022839),0.3943397899197747,0.9137012979245794,0.5650741350906096,0.9098796612675226,1.0,4/24,10.57%,ANO2;TTYH2;NMUR2;ANO6
prerank,protein kinase inhibitor activity (GO:0004860),-0.2936710601830306,-0.9130777210742895,0.5718654434250765,0.9196541664358646,1.0,12/42,15.69%,SPRED1;PARVA;TAOK3;CIT;DNAJC3;CAMK2N1;SPRED2;CDKN1A;CEP43;SMCR8;SNCA;CDKN1C
prerank,insulin-like growth factor I binding (GO:0031994),0.43168436229176393,0.9099425291447666,0.5696649029982364,0.9147151940374842,1.0,2/13,1.57%,ITGA6;INSR
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3374205896953315,-0.907838695676548,0.6134663341645885,0.9264890983386523,1.0,10/21,34.75%,FGF1;FGF2;FGF7;FGF10;NPTN;FGF18;KLB;FGF22;FGF9;FGF5
prerank,peptidase activator activity (GO:0016504),0.38900213764625413,0.9066441939318972,0.5917667238421955,0.9183753174786423,1.0,6/22,16.96%,CAV1;MAL;APH1A;PSME1;VSIR;CASP8AP2
prerank,ankyrin binding (GO:0030506),-0.3557349339636993,-0.9065770695301223,0.5833333333333334,0.9244075451041215,1.0,5/19,8.77%,CACNA1D;SLC8A1;CDH1;FLNC;NRCAM
prerank,GABA receptor binding (GO:0050811),-0.3991257373214873,-0.903814382815338,0.5904977375565611,0.9253452877378919,1.0,6/11,26.27%,ARFGEF2;TRAK1;SHISA7;PLCL2;GABARAP;JAKMIP1
prerank,transforming growth factor beta binding (GO:0050431),0.3842003699911568,0.9025450913384395,0.5973597359735974,0.9233941024362146,1.0,3/23,2.12%,ENG;ACVRL1;NRROS
prerank,omega peptidase activity (GO:0008242),0.3149746525458808,0.9024708733139495,0.62,0.9202537536578617,1.0,18/89,19.17%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;APEH;GGH;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.34402419980009447,0.9018972223919733,0.6053459119496856,0.9181588808760576,1.0,7/46,8.78%,LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,DNA secondary structure binding (GO:0000217),0.3639585212249657,0.9018548351224189,0.5829457364341085,0.9150345527331619,1.0,5/31,10.76%,MEF2C;LIN54;RAD51D;RAD18;XRCC2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.43104323811657735,0.901651286832872,0.582089552238806,0.9121765728104606,1.0,4/12,8.78%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,magnesium ion binding (GO:0000287),0.2971573557338941,0.9009288264681813,0.6494325346784363,0.9104729119875739,1.0,37/135,20.94%,SNRK;ERN1;PDE2A;SIK1;STK3;STK4;CDC42BPB;MAST2;SIK3;TSSK6;STK26;NEK6;DUT;NUDT16;HPRT1;FAN1;NT5C3A;ABL2;SIK2;STK38;MTPAP;MAP3K20;PDXP;ENDOV;IRAK3;RHEB;YDJC;NIM1K;PLSCR1;PRKACB;DHX36;NLK;PDCD6;MSH2;PGM1;MAP2K7;PLK1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.38918175301613206,0.8987716833725854,0.6112956810631229,0.905494651498531,1.0,1/22,1.96%,HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.38918175301613206,0.8987716833725854,0.6112956810631229,0.905494651498531,1.0,1/22,1.96%,HTR2A
prerank,serotonin receptor activity (GO:0099589),0.38918175301613206,0.8987716833725854,0.6112956810631229,0.905494651498531,1.0,1/22,1.96%,HTR2A
prerank,adrenergic receptor binding (GO:0031690),-0.3708465180252023,-0.898094243831987,0.6350710900473934,0.933692525496632,1.0,4/16,8.32%,MAGI2;DLG4;GNAS;ADRA2A
prerank,cation:chloride symporter activity (GO:0015377),0.45676713472699376,0.8970133974104518,0.6095764272559853,0.9058861694758716,1.0,2/10,7.82%,SLC12A7;SLC12A9
prerank,phosphatase binding (GO:0019902),0.3041876880409218,0.8958983090978905,0.6325757575757576,0.9050951781331898,1.0,20/105,10.56%,CTSC;IQGAP1;STAT3;PXN;FLT4;JAK3;CEACAM1;MAST2;SKAP1;CDKN1B;LCK;JAK1;PTK2;SNX3;SHOC2;ANAPC7;FBXL2;ANK1;AP3B1;SH3YL1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3731754079690668,0.8946970854818668,0.6013628620102215,0.9045038635134408,1.0,4/26,4.79%,ABCG2;SLC16A9;SLC16A2;SLC6A6
prerank,phosphatidic acid binding (GO:0070300),0.38945096079600383,0.8936130756400782,0.5912162162162162,0.903621096578914,1.0,8/19,23.07%,PLTP;RAPGEF2;PITPNC1;RAPGEF6;PACSIN2;OPA1;UQCC3;MAPKAP1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3733431574449332,-0.8933032761968923,0.5974683544303797,0.9337313313099171,1.0,4/16,12.90%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3733431574449332,-0.8933032761968923,0.5974683544303797,0.9337313313099171,1.0,4/16,12.90%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4225026876424947,0.8929556626257316,0.5875706214689266,0.9018541145389117,1.0,2/14,7.06%,KCNQ1;KCNE2
prerank,hexosaminidase activity (GO:0015929),-0.38926278882544124,-0.8923678334108717,0.6139954853273137,0.9305445078380324,1.0,6/12,31.97%,CEMIP;HEXA;HYAL1;NAGA;HYAL3;HEXD
prerank,aminopeptidase activity (GO:0004177),-0.321869077783251,-0.8911194812654842,0.6423173803526449,0.92818437378829,1.0,6/26,16.67%,MMP14;MMP16;NPEPPS;ENPEP;KDM8;BLMH
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2689119041604822,0.8881869739582013,0.7539936102236422,0.9084010347162161,1.0,58/346,14.49%,RNF125;SMURF1;RNF144B;RNF141;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;TRAF1;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;TRIM47;UBE2G1;RNF167;NEDD4;TRIM25;RNF139;MALT1;UBR1;TRIM24;UBE2H;NEURL3;NEURL1B;RNF146;FBXW2;RNF4;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;CUL1;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;ASB4;RNF215;FBXL3;UBE2K;TRAF6;TOPORS
prerank,SH2 domain binding (GO:0042169),0.3571328515258868,0.8859266447468452,0.6117455138662317,0.9097833968810649,1.0,8/31,8.98%,AFAP1L2;SH2B2;CCDC88A;SKAP1;LCK;PTK2;TRPV4;CRK
prerank,insulin-like growth factor binding (GO:0005520),0.4083706387027475,0.8822033649430495,0.5761245674740484,0.9142055667892656,1.0,2/15,1.57%,ITGA6;INSR
prerank,endoribonuclease activity (GO:0004521),0.35214661985427376,0.8806720698238597,0.6138147566718996,0.913992978666365,1.0,11/32,24.13%,ERN1;KHNYN;DICER1;INTS11;ZC3H12C;ENDOV;ENDOG;RIDA;LACTB2;SND1;SMG6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.39332429707709443,-0.8798567909607131,0.6284403669724771,0.9486451850342729,1.0,2/11,14.84%,AKR1B1;RDH13
prerank,phosphatase activity (GO:0016791),-0.2556613669614567,-0.8797515127088853,0.7307692307692307,0.9435932401287844,1.0,15/73,15.23%,ATP1A2;PLPP3;ALPL;PXYLP1;DUSP11;LPIN1;EPHX2;LHPP;DUSP10;PTPN22;SBF1;PPP1CB;PLPPR5;ACP6;APTX
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.30257441789600353,-0.8774713783478472,0.6641414141414141,0.9434807566918882,1.0,9/29,12.77%,SPRED1;YWHAG;PKIA;CIT;PRKAG2;PRKAR1B;SPRED2;PRKAR1A;CDKN1A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4290139470354001,0.8760338622057967,0.6138790035587188,0.9197260938292732,1.0,2/10,8.37%,GDA;DCTD
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.4290493916662198,0.874924499446607,0.5904936014625228,0.9187534749480489,1.0,4/12,17.69%,H3-3A;POU2F1;RELA;STAT1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3857420661482395,-0.8736523049946864,0.6361607142857143,0.9465843780965921,1.0,4/11,19.29%,HNRNPA2B1;RAD50;HNRNPA1;TERF2
prerank,bHLH transcription factor binding (GO:0043425),0.3915707449128936,0.8736443752585414,0.611965811965812,0.918316302696085,1.0,4/19,10.33%,LMO2;TCF12;TCF3;USF2
prerank,mannosyltransferase activity (GO:0000030),0.37455725563479486,0.8720905552631403,0.6101694915254238,0.9182906307675605,1.0,1/21,0.82%,TMTC2
prerank,sequence-specific mRNA binding (GO:1990825),-0.4025342132070913,-0.8713324898644328,0.6178489702517163,0.9464677516447122,1.0,5/10,28.89%,LARP6;SHFL;RBM24;SSB;DHX9
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3161434779332686,-0.8651152875696497,0.6482939632545932,0.9546335789065531,1.0,10/26,24.79%,AEBP1;CPXM2;CPXM1;AGBL4;CPM;AGBL1;ACE2;AGBL2;PEPD;CPZ
prerank,metal ion binding (GO:0046872),0.25698682742247864,0.862314048506204,0.8175182481751825,0.9342006853652348,1.0,58/477,11.66%,CSGALNACT1;MCTP1;TGM2;SNRK;LCP1;ERN1;PIR;PLA2G4A;IQGAP1;PDE2A;PPP3CA;PITPNM2;TPD52;SIK1;ESYT2;RASGRP3;STK3;SELP;CDH2;STK4;PADI4;CDC42BPB;ENPP2;SPARCL1;ASAH2;RET;MAST2;PAM;PPP3CB;CHP2;RAPGEF2;SIK3;PLA2G2D;FBP1;TSSK6;STK26;BNIP2;ITPR3;AGRN;CDH15;MICU2;PKD2;LPL;NEK6;IHH;DUT;NUDT16;CDH23;HPRT1;FAN1;CD320;NT5C3A;SYT15;ABL2;SIK2;STK38;GRIN1;CDHR5
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4112051306949555,0.8613199066496628,0.6379928315412187,0.9330328476467086,1.0,2/13,3.61%,KCNQ1;PRKAR2B
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.38774533919056775,0.860181942862072,0.6490299823633157,0.93215653069181,1.0,6/18,16.84%,TMOD3;PDLIM1;CNN3;STXBP6;PAK4;PDLIM5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36871965843141946,-0.8593469714351217,0.6473118279569893,0.9612943552060886,1.0,7/13,29.73%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC11A1;SLC9A4;SLC9A2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.37325092660642956,-0.8590205545697424,0.6895734597156398,0.9569191799989885,1.0,2/12,10.90%,CYFIP2;EIF4E3
prerank,filamin binding (GO:0031005),-0.3864490212611993,-0.8580875994254642,0.6653061224489796,0.9536375926139399,1.0,1/11,0.52%,DPYSL3
prerank,symporter activity (GO:0015293),-0.3849379963300974,-0.8579282282412989,0.6422222222222222,0.9488086154923763,1.0,3/10,14.18%,SLC5A5;SLC5A6;MFSD2A
prerank,chloride channel regulator activity (GO:0017081),0.4044987370831737,0.855512189338313,0.6241007194244604,0.9381999658941542,1.0,5/14,11.52%,STX7;STX1A;SGK3;VAMP8;STX8
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3445363918469473,0.853688107989307,0.6801242236024845,0.9385378270584688,1.0,8/32,15.19%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC25A38;SLC36A4;SLC7A5
prerank,amyloid-beta binding (GO:0001540),0.30035460764407657,0.8532027826280323,0.7189189189189189,0.936353306125876,1.0,13/79,11.71%,APBB2;INSR;FZD6;FZD4;BCHE;ATP1A3;CACNA1A;ITM2A;CLSTN1;EPHA4;ITGA2;GRIN1;PICALM
prerank,growth factor activity (GO:0008083),-0.2494605087050425,-0.8501830282237542,0.7735849056603774,0.9594715026551351,1.0,19/74,19.89%,PTN;FGF1;FGF2;IGF2;NGF;JAG1;NRG3;OSGIN2;VEGFB;VEGFA;INHBA;FGF7;HBEGF;MDK;PDGFA;FGF10;ANGPTL3;CLCF1;NTF3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3668752246747896,-0.8477611420432561,0.6901408450704225,0.9596070553488487,1.0,4/13,16.76%,AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,methylation-dependent protein binding (GO:0140034),0.31116332392646817,0.8428977526528386,0.6964809384164223,0.9522985416344425,1.0,16/57,19.77%,KMT2E;SPIN1;MTF2;CHD1;CDYL;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5
prerank,telomeric DNA binding (GO:0042162),0.3412752697711871,0.8426117246393666,0.6473354231974922,0.9497594982906428,1.0,12/32,24.13%,HMBOX1;RPA1;HNRNPD;SMG7;ACD;UPF2;TERF1;KDM1A;PURA;TEN1;TELO2;SMG6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3898451811373316,-0.8387164757851431,0.6767241379310345,0.9728043558985785,1.0,2/10,4.64%,ANO1;CLCN2
prerank,water transmembrane transporter activity (GO:0005372),-0.37730881236773306,-0.8385480925870038,0.6795918367346939,0.9680504479500418,1.0,1/11,1.60%,PDPN
prerank,ribosomal large subunit binding (GO:0043023),0.4039139455567401,0.8360740591525868,0.6683937823834197,0.9589226105672037,1.0,4/11,14.04%,RBM3;EIF6;MRRF;NPM1
prerank,chloride channel activity (GO:0005254),-0.25138600580147064,-0.835572447816512,0.839344262295082,0.9686826137002653,1.0,13/59,15.48%,SLC26A7;GLRB;ANO1;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;FXYD1;CLCN7
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24211761341757346,-0.8354213698431769,0.8192307692307692,0.9638736751971048,1.0,16/74,16.54%,NADK2;PI4KA;GK;FAM20C;FAM20A;GALK2;PAPSS2;DGKD;DGKI;HK2;DCAKD;SPHK1;PIK3CD;MVK;GALK1;DGKQ
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3410567982376195,-0.8339588296978787,0.6985645933014354,0.9616427622868646,1.0,12/15,53.52%,COX6B1;NDUFA4L2;COX4I2;COX7A1;NDUFA4;COX6A2;COX10;COX5B;COX15;COX8A;CYB5A;COX7A2L
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.36148064997357665,0.833955610063468,0.6617647058823529,0.9597212996347146,1.0,4/22,9.42%,RNF169;MINDY2;ZRANB1;IKBKG
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.42432848872493917,0.8339008905769036,0.6780952380952381,0.956725044131652,1.0,2/10,9.54%,CD200;IZUMO1
prerank,sodium channel regulator activity (GO:0017080),0.3218857796962706,0.83268020993739,0.6824925816023739,0.9559536859877024,1.0,5/37,8.61%,NEDD4L;FXYD6;ATP2B4;NEDD4;SGK3
prerank,disordered domain specific binding (GO:0097718),0.3544028439997037,0.8324569031103999,0.6836902800658978,0.953358042609024,1.0,8/23,22.19%,FYN;TEAD2;RB1;HSP90AB1;CALM1;NUMA1;SMAD2;FN1
prerank,carboxylic acid binding (GO:0031406),0.3283322462842009,0.8318874546830485,0.7005988023952096,0.951544086056075,1.0,3/38,8.53%,NOS3;PADI4;UBR1
prerank,sodium:proton antiporter activity (GO:0015385),-0.37485254035083415,-0.8292599816585171,0.6853448275862069,0.9657643216622761,1.0,6/11,29.73%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3875033760626345,0.827807288599872,0.6507666098807495,0.9557815455592322,1.0,2/15,6.69%,SLC39A8;SLC26A1
prerank,acetylation-dependent protein binding (GO:0140033),-0.313547183119484,-0.8271099797078197,0.7214285714285714,0.9600141646422043,1.0,9/20,16.75%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),-0.313547183119484,-0.8271099797078197,0.7214285714285714,0.9600141646422043,1.0,9/20,16.75%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3645306773669501,0.8268570324312583,0.67003367003367,0.9545346696116486,1.0,1/20,0.92%,SLC39A8
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3376205024887698,0.8267693892898355,0.6787974683544303,0.9517264541046578,1.0,2/30,3.36%,SLC39A8;SLC31A1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3638661788998642,0.8265152774928934,0.706645056726094,0.9462524177288849,1.0,3/21,9.30%,CDK6;CCNK;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3638661788998642,0.8265152774928934,0.706645056726094,0.9462524177288849,1.0,3/21,9.30%,CDK6;CCNK;CDK2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3419647672900226,0.8254357880741483,0.7215815485996705,0.9451680646960882,1.0,12/28,22.93%,MAP3K9;RPS6KA1;AURKA;AURKC;MAP2K3;MAPKAPK3;PRKCG;MAP2K5;MAP2K4;MAP2K7;MAP2K6;MAPK14
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3605919237861046,-0.822654460914915,0.7092511013215859,0.9642552203171654,1.0,2/12,12.13%,AOX1;FDX1
prerank,peptide hormone receptor binding (GO:0051428),-0.3493026176323134,-0.8209950155904506,0.6893203883495146,0.9625675130521971,1.0,8/11,50.82%,CCK;PSMC5;ADCYAP1;PTHLH;VIP;UCN2;GPHB5;GHRH
prerank,histone methyltransferase binding (GO:1990226),0.40006122872291816,0.8181084642788832,0.6963636363636364,0.9549600654222243,1.0,6/11,22.77%,LCORL;HSP90AB1;CTNNB1;LCOR;PRDM4;PHF1
prerank,tau protein binding (GO:0048156),-0.26777030626065584,-0.8167284785144866,0.773371104815864,0.9658716225563647,1.0,7/40,9.84%,ROCK2;MAP2;BRSK1;HSP90AA1;S100B;BIN1;APOE
prerank,MAP kinase kinase activity (GO:0004708),0.36734165406469327,0.8165609170305274,0.6817391304347826,0.9546141797150033,1.0,8/15,22.93%,MAP3K9;MAP2K3;MAPKAPK3;MAP2K5;MAP2K4;MAP2K7;MAP2K6;MAPK14
prerank,ligand-gated calcium channel activity (GO:0099604),-0.30677084938304044,-0.8103201429498589,0.7429305912596401,0.9726963939511438,1.0,4/19,13.74%,P2RX4;RYR2;GRIN2A;GRIN2D
prerank,nuclease activity (GO:0004518),0.30586076094706627,0.810256045600801,0.7280575539568346,0.9628317851624248,1.0,7/52,8.77%,SAMHD1;ISG20;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.399469090311562,0.8091525417406588,0.6805054151624549,0.9589545111446741,1.0,3/10,14.85%,DUSP16;DUSP7;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.399469090311562,0.8091525417406588,0.6805054151624549,0.9589545111446741,1.0,3/10,14.85%,DUSP16;DUSP7;DUSP2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.38418675078979003,0.8088182056019759,0.7009009009009008,0.956628566883106,1.0,3/14,21.24%,AK4;CMPK1;DTYMK
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34528655634071337,0.808429561125472,0.7003424657534246,0.9543681832887805,1.0,4/24,14.73%,ITPKB;AK4;CMPK1;PMVK
prerank,3'-5' exonuclease activity (GO:0008408),0.31085880067797694,0.8073230409800809,0.7346938775510204,0.9534815390105161,1.0,13/45,22.17%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;CNOT7;TRIR;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,miRNA binding (GO:0035198),-0.2749125011020159,-0.804854086092554,0.7851239669421488,0.9780187854832082,1.0,10/30,21.31%,HNRNPA2B1;AGO3;RBM4;ZC3H7B;HNRNPA1;DDX21;TUT4;ZNF346;SOX2;MATR3
prerank,ATPase regulator activity (GO:0060590),0.31088423612118116,0.8044302490595192,0.7155824508320726,0.9555195628229284,1.0,11/38,20.73%,FNIP2;DNAJA1;ATP1B3;GRPEL1;BAG4;BAG1;SIL1;DNAJB1;DNAJC10;DNAJB6;BAG2
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35846384317238117,-0.8037626434023276,0.740174672489083,0.9752083661254842,1.0,3/11,13.59%,CXCL12;ITCH;YARS1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3214729809551496,0.8036501365494506,0.7093206951026856,0.9539214002164279,1.0,15/34,26.17%,UBE2G1;UBE2H;UBE2D3;UBE2K;UBE2I;CDC34;UBE2Q1;UBE2L3;UBE2F;UBE2J2;UBE2D1;UBE2R2;UBE2E1;AKTIP;UBE2N
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3460759395111834,-0.8014383238062942,0.7375565610859729,0.9742532046445618,1.0,5/12,18.14%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,P-type ion transporter activity (GO:0015662),0.3837546570935087,0.8003483358958035,0.6885245901639344,0.9566152737822098,1.0,3/12,10.24%,ATP2B4;ATP2C1;ATP7B
prerank,pentosyltransferase activity (GO:0016763),-0.26529318985226047,-0.7980640220930018,0.7950819672131147,0.9752149716032206,1.0,8/36,17.30%,LARGE1;SIRT2;PARP3;PARP11;LACC1;QPRT;PARP8;ART3
prerank,cardiolipin binding (GO:1901612),-0.3711005600138364,-0.7947817011907898,0.7305122494432071,0.9758722893161464,1.0,1/10,4.03%,GSDME
prerank,receptor antagonist activity (GO:0048019),-0.30895934508986644,-0.7935659258734816,0.7270642201834863,0.9732589962994613,1.0,2/17,11.07%,DKK3;DKK2
prerank,DNA polymerase binding (GO:0070182),-0.3130416925613629,-0.7912747444974944,0.7688311688311689,0.9724047631089457,1.0,4/18,12.55%,HSP90AA1;RTEL1;SMARCA4;FANCI
prerank,mRNA binding (GO:0003729),0.24172127424345313,0.7907599298227086,0.9002242152466368,0.9696408015186435,1.0,49/249,16.02%,NANOS3;NOVA2;RBPMS;ADARB1;IGF2BP3;RPS14;RBM20;PTBP3;NANOS2;N4BP1;EDC3;CNBP;RPS7;HNRNPA0;HNRNPK;RBM14;SRBD1;MARF1;RBM25;THOC2;KHNYN;YBX3;NUDT16;G3BP1;PUM1;HNRNPLL;SERBP1;ANGEL2;RPL13A;YTHDC1;RC3H1;RBM15;RNPS1;MRPL13;PUM2;NUP98;HNRNPC;ZFP36;FMR1;SF3B6;QKI;ZC3H12C;LARP4B;NSRP1;RPS13;LSM14A;AQR;G3BP2;LUC7L2
prerank,RNA stem-loop binding (GO:0035613),-0.33379820970028695,-0.7905570517590476,0.7404063205417607,0.9688735944164404,1.0,3/12,15.35%,CPEB3;LARP6;RC3H2
prerank,chloride channel inhibitor activity (GO:0019869),0.39870750997064064,0.7900962317572415,0.6900584795321637,0.9678157676176954,1.0,4/10,11.52%,STX7;STX1A;VAMP8;STX8
prerank,histone demethylase activity (GO:0032452),0.3264029613077978,0.7889892339757141,0.7179080824088748,0.9665969106991676,1.0,10/27,22.76%,KDM3A;KDM6A;JMJD1C;KDM4C;JARID2;KDM5C;KDM4A;KDM1A;JMJD6;PHF2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.34965969318938717,-0.7885809420784053,0.7431818181818182,0.9676385083050252,1.0,5/11,18.14%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,MHC class I protein binding (GO:0042288),0.37727348259326143,0.7874035892765783,0.6980108499095841,0.9663331910517441,1.0,5/13,28.92%,TAP2;TAP1;TAPBP;ATP5F1B;ABCB9
prerank,endopeptidase activator activity (GO:0061133),0.388769025055548,0.7872390644897251,0.7001934235976789,0.9637568636184164,1.0,4/10,23.19%,APH1A;PSME1;VSIR;ADRM1
prerank,nucleosomal DNA binding (GO:0031492),-0.2955905047224257,-0.7869927385241781,0.7461139896373057,0.9654310456249192,1.0,8/21,23.59%,CHD4;SMARCA4;SMARCB1;MTA2;ACTL6A;RBBP4;SMARCD2;RCC1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2984182095839764,-0.7852036534572214,0.766497461928934,0.9636028513200862,1.0,5/22,12.90%,ATP6V0A4;ATP2A2;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.39311618740757015,0.7849636575344364,0.7166979362101313,0.9645716175285672,1.0,3/10,14.67%,CDKN1B;INCA1;KAT2B
prerank,carboxypeptidase activity (GO:0004180),-0.26362534378199304,-0.7831438068417267,0.8152173913043478,0.9621675799454228,1.0,11/35,19.05%,AEBP1;NAALAD2;CPXM2;CPXM1;AGBL4;SCPEP1;CTSZ;BLMH;CPM;AGBL1;ACE2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3371183089521462,0.7827718490700206,0.749185667752443,0.9655571936925312,1.0,4/20,13.77%,TJP2;AK4;MAGI3;CMPK1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.34638904160082223,-0.7817274782773768,0.7494553376906318,0.9600263595272033,1.0,6/12,29.73%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,NAD+ binding (GO:0070403),-0.3397687531827927,-0.7793815954971539,0.7564655172413793,0.9589415588886513,1.0,2/12,4.18%,CRYL1;SIRT2
prerank,protein kinase activator activity (GO:0030295),0.2795092743929654,0.7791664790964613,0.7962154294032023,0.9684368235275795,1.0,9/60,10.66%,IQGAP1;AFAP1L2;STK3;PAK2;STK4;RPLP1;RPTOR;RICTOR;GAS6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3178889071654769,-0.7786370891418021,0.7587006960556845,0.9556911368206535,1.0,4/15,16.76%,AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,signal sequence binding (GO:0005048),0.3080208039856895,0.7773160699487295,0.759375,0.9686225984031887,1.0,4/35,4.98%,NFKBIA;BABAM2;CAT;AP2B1
prerank,methyl-CpG binding (GO:0008327),-0.2926252461975863,-0.776082890737791,0.7686567164179104,0.9551638590897993,1.0,4/22,12.33%,TET1;CXXC4;ZBTB38;CXXC5
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3598922858183557,0.7758568140022721,0.7580372250423012,0.9680442440524714,1.0,5/14,19.56%,RPP30;RPP25;TSEN34;TSEN2;PRORP
prerank,WW domain binding (GO:0050699),0.3204129143176178,0.7743539550288647,0.7558528428093646,0.9675444671459945,1.0,7/26,20.23%,RAPGEF2;DAZAP2;CDC25C;PMEPA1;NDFIP2;LITAF;TCEAL9
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.351031361268638,0.7715215911093456,0.7327433628318584,0.969360953556932,1.0,3/17,21.24%,AK4;CMPK1;DTYMK
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.34072473394182534,-0.7708170651284958,0.7527839643652561,0.9583395128680248,1.0,3/11,14.00%,SLC5A3;SLC2A10;SLC5A11
prerank,phosphatidate phosphatase activity (GO:0008195),0.3648964800767409,0.7704159573813322,0.7375,0.9683109135243566,1.0,2/13,5.64%,PLPP1;LPIN3
prerank,MAP kinase phosphatase activity (GO:0033549),0.3697525327954293,0.7680069300238431,0.7336956521739131,0.9692600959372716,1.0,3/12,14.85%,DUSP16;DUSP7;DUSP2
prerank,microtubule plus-end binding (GO:0051010),-0.2967779884319566,-0.7666755069004437,0.8092783505154639,0.9598628299853083,1.0,3/20,6.34%,CLIP4;CLIP3;STIM1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3741373579221341,0.7663351916361604,0.7178502879078695,0.9690027786845437,1.0,2/10,4.19%,PRKAR2B;PKIG
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3149280460775703,-0.7649312364417286,0.8034934497816594,0.9581820853716618,1.0,1/15,2.77%,CCR9
prerank,methylated histone binding (GO:0035064),0.27592692681514785,0.7638860529246256,0.8237762237762237,0.9698646990213156,1.0,19/62,22.77%,KMT2E;SPIN1;MTF2;CHD1;CDYL;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5;TAF7;PHF2;PHF1
prerank,histone acetyltransferase activity (GO:0004402),0.3146600005796746,0.7612548976270379,0.7821138211382114,0.9710429857835537,1.0,8/30,16.89%,EPC1;ARRB1;KAT6B;HAT1;SRCAP;KAT2B;KAT6A;BAZ1A
prerank,myosin V binding (GO:0031489),0.35704092012204103,0.7606103585039703,0.7607142857142857,0.9692858087293552,1.0,5/15,22.83%,RAB11A;RAB11B;RAB6A;RAB25;RAB3A
prerank,muscle alpha-actinin binding (GO:0051371),-0.3093505184350863,-0.7590279312964147,0.8110047846889952,0.9621301420564701,1.0,5/15,16.89%,PALLD;PDLIM7;PDLIM4;LDB3;PDLIM2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.33442004149608595,-0.755940046650858,0.7851063829787234,0.9623018497821774,1.0,2/11,10.02%,NUDT4;NUDT7
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3014009501375121,0.7550881146818326,0.7755775577557755,0.9748750288616947,1.0,5/32,11.35%,KCNQ1;KCNB1;KCNE2;KCNG4;KCNA4
prerank,motor activity (GO:0003774),0.275481081137312,0.7535896702689137,0.8096632503660323,0.9742417828383947,1.0,12/60,12.55%,MYH9;STARD9;KIF26A;DNAH3;KIF22;MYO1E;DYNLRB1;KIF23;KIF19;DNAH17;MYL6B;KIF16B
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.35075530448860504,-0.7531403528513244,0.7822410147991543,0.9620678452783921,1.0,3/10,9.19%,ECHDC1;ECHDC3;ECHDC2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.31507760032950166,-0.7515822501133351,0.816414686825054,0.9599824035804889,1.0,4/13,29.28%,TARBP1;THUMPD3;METTL1;TRMT10B
prerank,R-SMAD binding (GO:0070412),-0.294744392366298,-0.7491638571191063,0.7857142857142857,0.9588157093003933,1.0,4/18,9.52%,DDX5;SMAD6;SMAD3;RGCC
prerank,CoA hydrolase activity (GO:0016289),-0.30391567200349734,-0.7491416729272192,0.8271028037383178,0.954617035026496,1.0,8/16,38.21%,ACOT11;NUDT7;ACOT9;ACOT8;ACOT1;ACOT7;HIBCH;ACOT12
prerank,epidermal growth factor receptor binding (GO:0005154),0.31481361919484685,0.7438049621199097,0.7914691943127962,0.9854808390958886,1.0,9/25,19.30%,HIP1;CCDC88A;TGFA;SNX4;SNX1;GRB2;PLSCR1;LINGO1;BTC
prerank,mRNA methyltransferase activity (GO:0008174),0.36134110572995654,0.7428599407487149,0.7495429616087751,0.9840195576599751,1.0,6/12,27.21%,RNMT;METTL14;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3585759988750637,0.7422039908365196,0.7602230483271375,0.9821751340609507,1.0,2/12,12.20%,OPN4;OPN5
prerank,transferrin receptor binding (GO:1990459),-0.33885224985495865,-0.738806793030584,0.7796610169491526,0.9636238234617931,1.0,3/10,11.16%,RGMA;CHUK;CD81
prerank,endonuclease activity (GO:0004519),0.2742348913375939,0.7342836144766393,0.8443465491923642,0.9904235700283346,1.0,7/49,14.45%,ERN1;ANG;KHNYN;DICER1;INTS11;ERCC4;ZC3H12C
prerank,snRNA binding (GO:0017069),-0.23687339526487716,-0.7338033557654794,0.9043478260869565,0.9656319339702408,1.0,11/42,25.22%,SNRNP70;DDX39B;CCNT2;CDK9;HNRNPU;DDX21;RNPC3;SNRPA1;RBM41;HEXIM2;SNRNP35
prerank,leucine zipper domain binding (GO:0043522),-0.32533249664665115,-0.7319132926975659,0.7804347826086957,0.9637578824921941,1.0,1/10,0.74%,PAWR
prerank,tubulin binding (GO:0015631),0.22441134954621092,0.7305721315724008,0.9675615212527964,0.9928190233073502,1.0,37/296,14.38%,DNM3;MTUS1;DIXDC1;RAB11A;ARHGEF2;REEP1;DST;STARD9;FYN;KIF26A;DIP2B;RAB11FIP5;MAST2;TTLL7;CCDC88A;MID2;TRPV4;KIF22;PHF6;ARHGEF7;TBCA;RAD51D;CEP57;PRUNE1;ARL8B;KIF23;KIF19;EML6;GABARAPL1;KIF16B;FMR1;PEX14;NDEL1;TTLL5;APC;S100A9;MID1
prerank,potassium:proton antiporter activity (GO:0015386),-0.34109943152386457,-0.729650299638497,0.8240343347639485,0.96213352387693,1.0,5/10,29.73%,SLC9A9;SLC9A1;SLC9A8;SLC9A4;SLC9A2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2441397520036242,-0.7277515109961261,0.90633608815427,0.9601813982500801,1.0,13/34,28.15%,KMT5A;EHMT2;SETDB1;DOT1L;SETD4;VCPKMT;MEN1;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3
prerank,GTPase inhibitor activity (GO:0005095),0.34157613343305177,0.7220466666918578,0.8050089445438283,1.0,1.0,1/13,2.10%,IQGAP1
prerank,tRNA methyltransferase activity (GO:0008175),-0.28545916485486655,-0.7214364428876271,0.8292682926829268,0.9634876432860148,1.0,10/16,44.88%,TARBP1;THUMPD3;BCDIN3D;METTL2B;METTL2A;THUMPD2;TRMT13;TRMT9B;TRMT44;FTSJ1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2911429314225673,0.719679133376431,0.8167202572347267,1.0,1.0,13/31,26.17%,UBE2G1;UBE2H;UBE2D3;UBE2K;CDC34;UBE2Q1;UBE2L3;UBE2J2;UBE2D1;UBE2R2;UBE2E1;AKTIP;UBE2N
prerank,translation elongation factor activity (GO:0003746),0.33441187569899217,0.7190790851233103,0.776536312849162,0.999674900591049,1.0,5/14,25.97%,EEFSEC;EEF2;EIF5A;EIF5AL1;GFM1
prerank,voltage-gated anion channel activity (GO:0008308),-0.2966522925676748,-0.7157379917085002,0.835214446952596,0.965931061223944,1.0,5/15,20.95%,ANO1;CLCN2;VDAC1;CLCN1;VDAC2
prerank,cholesterol binding (GO:0015485),0.2672819847440233,0.7082744813409863,0.8811292719167905,1.0,1.0,5/47,8.02%,CAV1;STARD5;PROM1;OSBPL10;SOAT2
prerank,monocarboxylic acid binding (GO:0033293),0.3180289205033539,0.7066539185445575,0.8197879858657244,1.0,1.0,2/18,6.56%,CYP26A1;CYP26C1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.31021361569116745,-0.7037139409083261,0.8172043010752689,0.975345602564124,1.0,7/10,40.34%,POLD1;EXO1;DCLRE1B;EXD2;FEN1;MGME1;TATDN1
prerank,exonuclease activity (GO:0004527),0.2665539292740324,0.7031520661545436,0.8555078683834049,1.0,1.0,9/46,15.01%,CNOT6;ISG20;ENPP2;FAN1;REXO2;EXOSC1;CNOT7;TRIR;XRN2
prerank,mannose binding (GO:0005537),0.3317033989121345,0.7025391083077319,0.813953488372093,1.0,1.0,3/12,26.58%,ACR;CLN5;LMAN2L
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3116551441273202,0.7016676521933002,0.8287671232876712,1.0,1.0,6/19,17.12%,AFAP1L2;PAK2;GREM1;GAS6;ALKAL2;ABI1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2759482951098236,0.7010621548040001,0.8623298033282905,1.0,1.0,10/34,24.69%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2759482951098236,0.7010621548040001,0.8623298033282905,1.0,1.0,10/34,24.69%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,methyltransferase activity (GO:0008168),-0.2236164608463759,-0.7003710387804148,0.9256756756756757,0.9746499504545258,1.0,23/46,38.53%,FTSJ3;METTL27;COQ5;LCMT1;NDUFAF7;ASMT;BUD23;EEF1AKMT1;NNMT;PRMT8;RRP8;BCDIN3D;EEF1AKMT3;AS3MT;NTMT1;PRMT7;MEPCE;COMTD1;EEF1AKMT4;AMT;PRMT1;EEF1AKMT2;METTL4
prerank,regulatory RNA binding (GO:0061980),-0.22493305022263155,-0.6996371899536281,0.9559228650137741,0.9712746982584376,1.0,11/38,22.41%,HNRNPA2B1;AGO3;RBM4;ZC3H7B;HNRNPA1;DDX21;TUT4;ZNF346;SOX2;MATR3;PIWIL2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2801712709153532,0.6949216906385779,0.8557844690966719,1.0,1.0,3/31,8.08%,SLC12A7;SLC12A9;PKD2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2531319641871652,0.6922393996325129,0.9044862518089725,1.0,1.0,8/60,7.19%,PPP3CA;PPM1F;PPM1L;PPP3CB;MTMR6;PGAM5;PPM1D;LCK
prerank,death receptor binding (GO:0005123),0.31577396248535144,0.6902089364252998,0.8252595155709342,1.0,1.0,5/15,19.21%,DAB2IP;RIPK1;BID;CASP8AP2;MADD
prerank,nuclear localization sequence binding (GO:0008139),0.30666293253041105,0.6879277435895961,0.8356890459363958,1.0,1.0,5/18,21.53%,NFKBIA;NUP214;NUP153;KPNB1;KPNA4
prerank,phospholipase activity (GO:0004620),0.2488747683566333,0.6869641068219323,0.9263301500682128,1.0,1.0,7/67,9.99%,PLCB4;PLA2G4A;ENPP2;PLA2G2D;LPL;PLAAT3;GDPD1
prerank,microtubule binding (GO:0008017),0.21377281777094512,0.6866694618220465,0.9791425260718424,1.0,1.0,31/222,16.82%,DNM3;MTUS1;RAB11A;ARHGEF2;REEP1;DST;STARD9;KIF26A;MAST2;CCDC88A;MID2;TRPV4;CAMSAP2;KIF22;CEP57;KIF23;KIF19;EML6;KIF16B;FMR1;PEX14;NDEL1;APC;S100A9;MID1;CEP290;CHP1;TERF1;CEP295;FNTA;ABRAXAS2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.331333443798983,0.6785542928517196,0.8155893536121673,1.0,1.0,3/10,18.34%,NAA11;NAA16;NAA30
prerank,translation initiation factor activity (GO:0003743),0.2674084871515331,0.6750213913153207,0.8923556942277691,1.0,1.0,8/36,15.99%,EIF4E;EIF3H;EIF1;EIF2B5;EIF5B;EIF2B2;MTIF3;EIF5
prerank,3'-5' DNA helicase activity (GO:0043138),-0.2675087969657363,-0.6728980585975488,0.9025522041763341,0.9930931710490861,1.0,2/16,6.00%,NAV2;RECQL5
prerank,RNA polymerase II complex binding (GO:0000993),-0.22861254854515567,-0.6701545701281494,0.9128205128205128,0.9915444935809026,1.0,8/32,19.53%,RECQL5;CTR9;PAF1;ERCC5;WDR43;HNRNPU;UVSSA;ELP4
prerank,snoRNA binding (GO:0030515),0.2731781101472777,0.6700866204292002,0.8634146341463415,1.0,1.0,8/30,18.89%,IMP3;ISG20;NUDT16;RRP9;UTP6;HEATR1;NOP14;NUDT1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3090470044071989,0.6696361926377222,0.8834244080145719,1.0,1.0,2/15,7.41%,PIK3C2A;PIK3CG
prerank,death domain binding (GO:0070513),0.3273887273731463,0.665423499080899,0.851024208566108,1.0,1.0,5/11,16.23%,CRADD;BCL2L1;RIPK1;RACK1;IRGM
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.25233009501019665,0.6551252939139495,0.9270186335403726,1.0,1.0,8/42,17.36%,CCNK;CDKN1B;CCNYL1;CCNY;INCA1;KAT2B;CCNJ;CCNC
prerank,aspartic-type peptidase activity (GO:0070001),0.3232704438799593,0.6528458037036338,0.847985347985348,1.0,1.0,4/10,26.86%,PSEN1;DDI2;NAPSA;CTSE
prerank,RNA methyltransferase activity (GO:0008173),0.2891131648240555,0.6456881805242279,0.8781302170283807,1.0,1.0,3/19,13.10%,TGS1;FBLL1;HENMT1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2891588047693554,-0.6436278944250028,0.8991228070175439,1.0,1.0,4/11,27.58%,APEX2;NEIL3;NTHL1;NEIL1
prerank,kinase inhibitor activity (GO:0019210),0.2606716995143001,0.6427948490633788,0.9161392405063291,1.0,1.0,11/33,19.79%,NCK1;CDKN1B;GMFG;WARS1;TRIB1;GSKIP;NPM1;MBIP;SH3BP5L;PRKRIP1;DUSP19
prerank,ubiquitin binding (GO:0043130),0.22835324573572602,0.6421479623550762,0.9675141242937854,1.0,1.0,22/73,23.19%,MVB12B;FBXW7;N4BP1;NEDD4;IKBKG;VPS28;RAD23A;CXCR4;BUB3;ILRUN;UBXN1;DDI2;BIRC2;WDR48;GGA3;USP25;TSG101;VPS36;UBXN2A;FBXO7;UCHL3;ADRM1
prerank,microtubule minus-end binding (GO:0051011),0.29595068502447364,0.6399695737470755,0.8837209302325582,1.0,1.0,7/13,29.48%,CAMSAP2;CEP290;NUMA1;TUBGCP2;CAMSAP1;HAUS4;TUBGCP3
prerank,ribosome binding (GO:0043022),-0.20249085303287817,-0.6383109071875479,0.9725609756097561,1.0,1.0,8/46,16.53%,CPEB1;CPEB2;CPEB3;CPEB4;EIF3C;SHFL;SEC61A2;IGHMBP2
prerank,lipase activity (GO:0016298),0.24430250768579312,0.635742695308679,0.9234167893961709,1.0,1.0,8/43,18.95%,ABHD2;LIPE;LPL;PNPLA2;PNPLA8;FAAH;CEL;LIPA
prerank,neuropeptide receptor activity (GO:0008188),-0.22258792151517387,-0.624426700489137,0.9582089552238806,1.0,1.0,3/29,7.45%,SORCS2;SORCS1;SORCS3
prerank,exopeptidase activity (GO:0008238),0.23076935674346216,0.6210518340999885,0.9581464872944694,1.0,1.0,9/50,15.60%,PRCP;CPE;PM20D2;ERAP1;NUDT16;LAP3;GGH;ACE;ZMPSTE24
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2788861938294474,0.6188551972544735,0.905,1.0,1.0,2/18,13.32%,RDH16;SRD5A2
prerank,NADPH binding (GO:0070402),0.29297152574215674,0.6184256461039611,0.8942652329749103,1.0,1.0,1/13,3.41%,LBR
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.29677225791655626,0.6170805462248774,0.8919382504288165,1.0,1.0,3/12,18.17%,CBR1;CBR4;NQO2
prerank,hormone activity (GO:0005179),-0.19191907674925163,-0.6161558887385901,0.9933774834437086,1.0,1.0,1/54,0.34%,IGF1
prerank,channel activity (GO:0015267),0.2395094632368231,0.6161462731318829,0.9494640122511485,1.0,1.0,6/41,14.87%,AQP11;TRPV6;TRPV4;MCUB;PANX1;CHRNB1
prerank,microtubule motor activity (GO:0003777),0.22941109340241317,0.6125592395631405,0.954954954954955,1.0,1.0,9/51,12.55%,STARD9;KIF26A;DNAH3;KIF22;DYNLRB1;KIF23;KIF19;DNAH17;KIF16B
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2933210181863491,0.6120499228758236,0.8929219600725953,1.0,1.0,3/13,15.10%,DICER1;FAN1;ENDOV
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.21820606555657163,-0.608086153750108,0.9523809523809523,1.0,1.0,3/25,7.76%,SIRT2;PARP3;PARP11
prerank,N-acetyltransferase activity (GO:0008080),0.27045521248787435,0.6069816115088236,0.9176470588235294,1.0,1.0,3/19,14.67%,NAT2;SMARCE1;KAT2B
prerank,Hsp70 protein binding (GO:0030544),0.24250957393518532,0.6014636129927846,0.9415584415584416,1.0,1.0,2/31,6.77%,ERN1;DNAJA1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2369497565129345,0.6004172781235516,0.9376947040498442,1.0,1.0,13/35,33.08%,PTRH1;NT5C3A;DTWD2;QRSL1;MTFMT;AARS2;LCMT2;TRMT12;TRIT1;GATC;ALKBH1;TYW3;PUS10
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.23798439466624194,-0.593543112014296,0.9501187648456056,1.0,1.0,7/17,33.80%,ACOT11;PPT1;PLA2G6;ACOT9;ACOT8;ACOT1;ACOT7
prerank,5'-nucleotidase activity (GO:0008253),0.28385498525890057,0.593520517217481,0.9183673469387755,1.0,1.0,2/13,10.88%,NT5C2;NT5C3A
prerank,histone methyltransferase activity (GO:0042054),-0.1999119199074792,-0.5909575654569243,0.9706744868035191,1.0,1.0,12/32,30.36%,KMT5A;EHMT2;SETDB1;DOT1L;CARM1;MEN1;PRMT8;FBL;PRMT2;SETD7;NTMT1;PRMT7
prerank,O-methyltransferase activity (GO:0008171),-0.2695661943858514,-0.5878787059015803,0.9381898454746137,1.0,1.0,4/10,31.09%,FTSJ3;ASMT;BCDIN3D;MEPCE
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.25559956627022934,0.5821026684695836,0.9376083188908145,1.0,1.0,7/20,19.17%,EIF3H;COPS2;YOD1;DESI2;USP7;USP25;USP21
prerank,CCR chemokine receptor binding (GO:0048020),-0.2081975284177257,-0.5819567958063045,0.9706666666666667,1.0,1.0,17/28,47.43%,NES;CCL19;CCR2;CCL2;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2549856751254874,0.5811531481066833,0.9432739059967585,1.0,1.0,4/22,11.71%,MESD;DNAJA1;AP2A1;PICALM
prerank,acetyltransferase activity (GO:0016407),-0.20005984941213445,-0.577928884478915,0.9629629629629629,1.0,1.0,6/31,15.54%,PAFAH2;ACAT1;SPHK1;SAT1;KAT8;PAFAH1B2
prerank,four-way junction DNA binding (GO:0000400),-0.22589154241029635,-0.5779155098280353,0.95260663507109,1.0,1.0,7/17,24.98%,RAD51B;MSH6;HMGB2;MEN1;RAD51C;GEN1;XRCC3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.26399648505794704,0.5760980516854264,0.9102564102564102,1.0,1.0,2/14,11.89%,RDH16;ADH1A
prerank,ATPase activator activity (GO:0001671),0.24899343690585626,0.5759312782061572,0.9426086956521739,1.0,1.0,5/20,20.03%,DNAJA1;ATP1B3;DNAJB1;DNAJC10;DNAJB6
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.20832199658828882,-0.5747599980605698,0.9782608695652174,1.0,1.0,11/27,31.43%,POLR2B;POLR3H;MED20;POLRMT;POLR2I;TERT;MED21;POLR3K;POLR2D;CRCP;POLR2G
prerank,acetylcholine receptor activity (GO:0015464),-0.21065003582727743,-0.5664319712199959,0.9774436090225563,1.0,1.0,14/22,47.85%,CHRFAM7A;CHRNA7;CHRM3;CHRM2;CHRM1;CHRNB2;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.22159028193326039,0.5634750136400738,0.9693548387096774,1.0,1.0,8/33,18.93%,ZNF326;RRN3;RPRD1B;ESRRB;RPRD2;ERBB2;CDC73;RPRD1A
prerank,glutathione transferase activity (GO:0004364),0.23628328851021152,0.5577680839032033,0.9534510433386838,1.0,1.0,4/23,12.62%,ALOX5AP;GSTA4;LTC4S;GSTP1
prerank,single-stranded DNA binding (GO:0003697),0.18624467332358227,0.5527435065381995,0.9972972972972973,1.0,1.0,12/93,13.01%,SAMHD1;MCM10;RPA1;POLA1;SUB1;RAD51D;MEIOB;RAD23A;LONP1;MCM9;ERCC4;TOP1
prerank,C-C chemokine receptor activity (GO:0016493),0.2337004105625018,0.5485720389847574,0.9534482758620689,1.0,1.0,4/21,20.77%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,nucleotidase activity (GO:0008252),0.25158806618464336,0.5473307487847336,0.9477477477477477,1.0,1.0,2/15,10.88%,NT5C2;NT5C3A
prerank,neuropeptide receptor binding (GO:0071855),-0.22903640333846673,-0.5460152087565412,0.9685393258426966,1.0,1.0,4/14,30.79%,SHANK1;NPY;NTS;APLN
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17607787492817487,-0.5436671874217704,0.996875,1.0,1.0,19/40,34.85%,DNMT3A;HNMT;TARBP1;LCMT1;TPMT;ASMT;NNMT;PRMT8;FBL;THUMPD3;RRP8;AS3MT;METTL18;PRMT7;GNMT;MEPCE;COMTD1;METTL2B;METTL2A
prerank,ribonuclease P activity (GO:0004526),0.2644229363001199,0.5394619370780095,0.9584837545126353,1.0,1.0,5/11,27.98%,RPP30;RPP25;PRORP;RPP38;RPP14
prerank,calcium-release channel activity (GO:0015278),0.24119821185898094,0.5383247081543352,0.9445378151260504,1.0,1.0,2/17,8.08%,ITPR3;PKD2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22121881638440466,0.5370169441031657,0.9732704402515723,1.0,1.0,9/27,26.09%,POLR1A;PRIMPOL;POLR1B;POLR3B;POLR3A;POLR2L;POLR2J;POLR3F;PRIM1
prerank,ribonuclease P RNA binding (GO:0033204),0.26751645247450184,0.5369707067720965,0.9541284403669725,1.0,1.0,2/10,12.19%,RPP30;RPP25
prerank,tRNA binding (GO:0000049),0.20179844641366312,0.5339021072823499,0.9800307219662059,1.0,1.0,19/43,32.41%,FARS2;EIF2AK4;AIMP1;KARS1;XPOT;YRDC;TRNAU1AP;NSUN6;ALKBH8;AARS2;TRMT10C;NSUN2;CARS1;RPUSD4;TRMT10A;NEMF;ALKBH1;TYW5;EIF2A
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.2657479604186369,0.5318189828572147,0.9546279491833031,1.0,1.0,4/10,28.45%,SETD5;PRDM9;NSD2;SMYD2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.22119655382674908,-0.5306992673147398,0.9788732394366197,1.0,1.0,3/14,22.39%,ACO2;NFU1;RSAD2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.2102580252140392,-0.5239678498348952,0.9839816933638444,1.0,1.0,6/15,31.83%,KMT2D;SETMAR;SETD4;SETD1A;WDR5;WDR82
prerank,ATP hydrolysis activity (GO:0140603),0.20268144791458395,0.5235774140698168,0.9876543209876543,1.0,1.0,6/41,13.49%,KIF26A;SMCHD1;ABCA3;MYO1E;ABCD1;TOR3A
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.18914644533170272,-0.5196703793888079,0.9973544973544973,1.0,1.0,2/24,8.44%,GLUL;ZDHHC20
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.1893875178872478,0.5155091277377002,0.9943342776203966,1.0,1.0,13/57,24.79%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;UQCRQ;NDUFS4;NDUFS6;UQCRC1;NDUFB9;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,vitamin D receptor binding (GO:0042809),0.23926953743905843,0.5139975506589131,0.9549393414211439,1.0,1.0,4/14,22.79%,SNW1;TAF7;MED12;MED17
prerank,damaged DNA binding (GO:0003684),-0.16260759930989943,-0.5123340147005843,0.9969230769230769,0.9988488755331523,1.0,17/44,32.49%,CRY2;DDB2;ERCC5;APTX;DDB1;XPC;HMGB2;NEIL3;SMC6;TDG;NTHL1;POLD1;RAD1;DCLRE1B;RPA2;ERCC1;FEN1
prerank,neuropeptide hormone activity (GO:0005184),0.2219360512595011,0.5089023732861679,0.9802306425041186,1.0,1.0,22/22,77.84%,UCN;AGRP;PPY;NPFF;SPX;GAL;PNOC;OXT;CORT;NMB;QRFP;HCRT;GHRH;NPPA;CALCB;CRH;PENK;VIP;GRP;ADCYAP1;NPY;CCK
prerank,chemokine receptor binding (GO:0042379),0.2023465103404069,0.5087327118682087,0.9891472868217054,1.0,1.0,3/35,10.40%,CX3CR1;PPBP;CCL14
prerank,palmitoyltransferase activity (GO:0016409),0.20976840365476093,0.4973268529865006,0.9903069466882067,1.0,1.0,9/28,23.64%,ZDHHC18;ZDHHC9;HHAT;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC17;ZDHHC2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.21913404001638756,-0.4937787475683846,0.9669603524229075,0.9994773711042345,1.0,3/11,21.57%,NAA40;NAA80;NAA60
prerank,chemokine activity (GO:0008009),-0.16476152773212768,-0.48458913207304616,0.9945504087193461,0.9972406827957473,1.0,12/31,39.19%,CXCL16;CXCL12;CCL19;CCL2;CCL28;CCL5;CXCL5;CCL11;CCL4;PF4;CCL7;CCL8
prerank,deoxyribonuclease activity (GO:0004536),-0.19638932315535626,-0.48058439951800713,0.9933333333333333,0.9940909723771298,1.0,6/14,36.99%,ERCC5;MAP1S;DNASE1L2;DNASE1L1;ZRANB3;APLF
prerank,chemokine receptor activity (GO:0004950),0.19560717887135934,0.464682887025945,0.9898648648648649,1.0,1.0,4/24,20.77%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.22633191622529053,0.4612834195323952,0.9721254355400697,1.0,1.0,1/11,7.74%,ITPR3
prerank,N-methyltransferase activity (GO:0008170),0.20244980892524944,0.4607598208606104,0.9812286689419796,1.0,1.0,3/20,12.87%,TFB2M;PEMT;RNMT
prerank,single-stranded DNA helicase activity (GO:0017116),0.20518779047858332,0.4571420364372223,0.9875444839857651,1.0,1.0,19/19,79.51%,HELB;RFC3;RFC5;MCM6;RFC2;MCM7;MCM2;RAD51;RFC4;MCM5;WRNIP1;POLQ;PIF1;CHTF8;CHTF18;DHX9;DSCC1;HELQ;DNA2
prerank,pseudouridine synthase activity (GO:0009982),0.21756554952014445,0.44923331152956625,0.9838709677419355,1.0,1.0,7/13,30.36%,PUS7L;TRUB1;RPUSD2;PUS7;PUSL1;RPUSD4;RPUSD1
prerank,single-stranded RNA binding (GO:0003727),0.17039139247168955,0.44820166514787424,0.9984756097560976,1.0,1.0,7/43,15.60%,HNRNPF;CNBP;LONP1;IFIH1;FMR1;ENDOV;AQR
prerank,beta-tubulin binding (GO:0048487),0.17966154253836011,0.4454465314486295,0.9968253968253968,1.0,1.0,9/31,22.68%,TTLL7;TRPV4;ARL8B;GABARAPL1;PEX14;RACGAP1;UXT;TAOK1;APPL1
prerank,endodeoxyribonuclease activity (GO:0004520),0.18880714645994873,0.4342092522742305,0.9894366197183099,1.0,1.0,9/20,28.27%,ERCC4;ENDOV;DCLRE1C;ENDOG;RPS3;MBD4;APEX1;RBBP8;EXOG
prerank,proton transmembrane transporter activity (GO:0015078),0.17240815622488792,0.43244910556411065,0.9969418960244648,1.0,1.0,2/39,6.35%,CLCN3;OTOP2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.1926916556790357,0.4142394386807223,0.9783393501805054,1.0,1.0,14/14,80.75%,CAPN5;CAPN12;CAPN3;CAPN10;CAPN13;CAPN9;CAPNS2;CAPN11;CAPN8;CAPN15;CAPNS1;CAPN1;CAPN6;CAPN2
prerank,MHC protein binding (GO:0042287),0.1811998075068322,0.4140751986690515,0.9967159277504105,1.0,1.0,1/20,5.77%,TAP2
prerank,nuclear import signal receptor activity (GO:0061608),-0.16547165581042023,-0.40476024880878225,1.0,0.9982396277626987,1.0,8/15,41.61%,TNPO2;KPNA2;IPO5;KPNA3;IPO9;IPO4;KPNA6;KPNA7
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.18443188951663536,0.3712306129280077,1.0,1.0,1.0,11/11,81.57%,CHRNB1;CHRNA9;CHRNA4;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB2;CHRNA7
prerank,ferrous iron binding (GO:0008198),0.15388926040122303,0.3532112250421136,1.0,0.9991803278688525,1.0,5/21,23.66%,EGLN1;TET2;ACP5;EGLN2;FXN
